Drug_Name Pilot1_Drug_ID Broad_ID SMILES Target_Gene(Symbol) Target_Gene(Entrez_ID) MoA_Description MoA_Category KW-2449 CTRP.298 BRD-K21718444 O=C(N1CCNCC1)c1ccc(cc1)\C=C\c1n[nH]c2ccccc12 ABL1;AURKA;AURKB;FLT3 25;6790;9212;2322 Abl kinase inhibitor; Aurora kinase inhibitor; FLT3 inhibitor ABL and/or SRC signaling; Mitosis; RTK signaling NILOTINIB CTRP.378;GDSC.1013;CCLE.2 BRD-K81528515 Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F ABL1;KIT 25;3815 Abl kinase inhibitor; Bcr-Abl kinase inhibitor ABL and/or SRC signaling BOSUTINIB CTRP.158 BRD-K90746395 COc1cc(Nc2cc(nc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl ABL1;BCR;CAMK1D;CAMK2G;CDK2;FRK;FYN;HCK;LYN;MAP2K1;MAP2K2;MAP3K2;MAP4K5;SRC;STK10;STK24;STK4;TNK2;TXK 25;613;57118;818;1017;2444;2534;3055;4067;5604;5605;10746;11183;6714;6793;8428;6789;10188;7294 Abl kinase inhibitor; Bcr-Abl kinase inhibitor; src inhibitor ABL and/or SRC signaling BOSUTINIB GDSC.1019 BRD-K99964838 CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC ABL1;BCR;CAMK1D;CAMK2G;CDK2;FRK;FYN;HCK;LYN;MAP2K1;MAP2K2;MAP3K2;MAP4K5;SRC;STK10;STK24;STK4;TNK2;TXK 25;613;57118;818;1017;2444;2534;3055;4067;5604;5605;10746;11183;6714;6793;8428;6789;10188;7294 Abl kinase inhibitor; Bcr-Abl kinase inhibitor; src inhibitor ABL and/or SRC signaling CI-976 CTRP.174 BRD-K88544581 CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC ACAT1;CES1 38;1066 ACAT inhibitor Other BRD-K03536150 CTRP.63 BRD-K03536150 CC1=NN(C(=O)C\1=N\Nc1ccccc1C(O)=O)c1nc(cs1)-c1ccccc1 BAX 581 activator of BAX Other ML083 CTRP.323 BRD-K44241590 COc1ccc(cc1)S(=O)(=O)N1CCN(CC1)S(=O)(=O)c1ccc2OCCOc2c1 PKM 5315 activator of muscle pyruvate kinase "Other, kinases" SCH-529074 CTRP.447 BRD-K24376488 CN(C)CCCNc1nc(CN2CCN(CC2)C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)nc2ccccc12 TP53 7157 activator of mutant p53 p53 pathway ISTRADEFYLLINE CTRP.279 BRD-K87774949 CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O ADORA1;ADORA2A;ADORA2B;ADORA3 134;135;136;140 adenosine receptor antagonist Other AICA RIBONUCLEOTIDE GDSC.1001 BRD-A67373739 C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N ATIC;PRKAA1 471;5562 adenosine release stimulant; AMPK stimulant Metabolism ATRA CTRP.19 BRD-K64634304 CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C RARA;RARB;RARG 5914;5915;5916 agonist of retinoid acid receptors Retinoic acid receptor and retinoid X receptor modulator ML006 CTRP.320 BRD-K89692698 C1CN(CCO1)c1nnc(-c2ccccc2)c(n1)-c1ccccc1 S1PR3 1903 agonist of sphingosine 1-phosphate receptor 3 Sphingosine 1-phosphate receptor modulator ELOCALCITOL CTRP.226 BRD-A04287157 CCC(O)(CC)\C=C\CC(C)C1=CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](F)C1=C VDR 7421 agonist of vitamin D receptor Metabolism MK-2206 CTRP.319;GDSC.1053 BRD-K68065987 NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1 AKT1;AKT2;AKT3 207;208;10000 AKT inhibitor PI3K/MTOR signaling A-443654 GDSC.86 CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N AKT1;AKT2;AKT3 207;208;10000 AKT inhibitor PI3K/MTOR signaling AKT INHIBITOR VIII GDSC.171;GDSC.228 AKT1;AKT2;AKT3 207;208;10000 AKT inhibitor PI3K/MTOR signaling GSK690693 GDSC.326 BRD-K25325018 CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N AKT1;AKT2;AKT3;PAK4;PAK6;PAK5;PRKCQ;PRKG1;PRKX 207;208;10000;10298;56924;57144;5588;5592;5613 AKT inhibitor PI3K/MTOR signaling AT7867 CTRP.18 BRD-K12040459 Clc1ccc(cc1)C1(CCNCC1)c1ccc(cc1)-c1cn[nH]c1 AKT2;GSK3B;PKIA;PRKACA 208;2932;5569;5566 AKT inhibitor PI3K/MTOR signaling TAE684 CTRP.492;GDSC.35;CCLE.22 BRD-K50140147 COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1 ALK;INSR 238;3643 ALK tyrosine kinase receptor inhibitor RTK signaling CRIZOTINIB CTRP.201;GDSC.37;CCLE.8;gCSI.3 BRD-K78431006 C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl ALK;MET 238;4233 ALK tyrosine kinase receptor inhibitor RTK signaling ALECTINIB GDSC.281 BRD-K11267252 ALK;MET 238;4233 ALK tyrosine kinase receptor inhibitor RTK signaling SB505124 GDSC.1194 BRD-K40109029 TGFBR1 7046 ALK tyrosine kinase receptor inhibitor RTK signaling PHENFORMIN GDSC.196 BRD-K11399644 NC(=N)NC(=N)NCCc1ccccc1 KCNJ8;PRKAA1 3764;5562 AMPK activator Other COMPOUND 23 CITRATE CTRP.199 BRD-K67112618 CN(C)[C@H]1CC[C@H]2[C@@H](CC[C@H]3[C@@H]4CC=C(c5ccc6cnccc6c5)[C@@]4(C)CC[C@H]23)C1 analog of natural product cortistatin Other COL-3 CTRP.181 BRD-A59431241 NC(=O)C1C(=O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3C(=O)[C@]2(O)C1=O analog of tetracycline Other BRD-K26531177 CTRP.79 BRD-K26531177 COc1cc(CCC(=O)N2CCC=CC2=O)cc(OC)c1OC analog of the natural product piperlongumine Other BRD-K34222889 CTRP.92 BRD-K34222889 COc1ccc(cc1)C#CC1=CCCN(C(=O)\C=C\c2cc(OC)c(OC)c(OC)c2)C1=O analog of the natural product piperlongumine Other ABIRATERONE CTRP.30 BRD-K50071428 C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c1cccnc1 CYP11B1;CYP17A1 1584;1586 androgen biosynthesis inhibitor Hormone-related BICALUTAMIDE GDSC.150;GDSC.1502 BRD-A29485665 CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O AR 367 androgen receptor antagonist Hormone-related KIN001-236 GDSC.286 TEK 7010 Angiopoietin-1 receptor Other BMS-270394 CTRP.49 BRD-K04905989 CC1(C)CCC(C)(C)c2cc(ccc12)[C@@H](O)C(=O)Nc1ccc(cc1F)C(O)=O RARG 5916 antagonist of retinoic acid receptor gamma Retinoic acid receptor and retinoid X receptor modulator BMS-195614 CTRP.48 BRD-K45935533 CC1(C)CC=C(c2cnc3ccccc3c2)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O RARA;RARB;RARG 5914;5915;5916 antagonist of retinoic acid receptors Retinoic acid receptor and retinoid X receptor modulator GSK4112 CTRP.253 BRD-K78667050 CC(C)(C)OC(=O)CN(Cc1ccc(s1)[N+]([O-])=O)Cc1ccc(Cl)cc1 NR1D1 9572 antagonist of Rev-ErbAalpha Other SR8278 CTRP.460 BRD-A02904414 CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1 NR1D1 9572 antagonist of Rev-ErbAalpha Other LENALIDOMIDE GDSC.1020 BRD-A17883755 C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N CDH5;CRBN;PTGS2;TNF;TNFSF11 1003;51185;5743;7124;8600 anticancer agent Protein stability and degradation BRD-K97651142 CTRP.132 BRD-K97651142 CN(CCc1cc(Br)c(OCCCNc2ncnc3n(C)cnc23)c(Br)c1)C(=O)c1ccc(C)cc1 aphrocallistin derivative Other YK 4-279 CTRP.540;GDSC.1239 BRD-A62182663 COc1ccc(cc1)C(=O)CC1(O)C(=O)Nc2c1c(Cl)ccc2Cl EWSR1;FLI1 2130;2313 apoptosis inhibitor Apoptosis regulation NSC19630 CTRP.352 BRD-K39706510 CCC(=O)OCN1C(=O)C=CC1=O apoptosis stimulant Apoptosis regulation DARINAPARSIN CTRP.212 BRD-K35723520 C[As](C)SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O apoptosis stimulant; NADPH oxidase stimulant Inducer of ROS; Apoptosis regulation BETULINIC-ACID CTRP.152 BRD-K45401373 CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O GPBAR1 151306 apoptosis stimulant; NFkB pathway inhibitor Apoptosis regulation; Modulator of NF-kappa-B signaling QS11 CTRP.430 BRD-K02526760 OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3CCCc3c2)nc2n(Cc3ccc(cc3)-c3ccccc3)cnc12 ARFGAP1 55738 ARFGAP inhibitor Other QS11 GDSC.151 BRD-K02526760 C1CC2=C(C1)C=C(C=C2)OC3=NC4=C(C(=N3)NC(CC5=CC=CC=C5)CO)N=CN4CC6=CC=C(C=C6)C7=CC=CC=C7 ARFGAP1 55738 ARFGAP inhibitor Other STEMREGENIN 1 CTRP.490 BRD-K36739687 CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(nc12)-c1csc2ccccc12 AHR 196 aryl hydrocarbon receptor antagonist Other KU-60019 CTRP.297 BRD-K36016295 C[C@H]1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)C[C@@H](C)O1 ATM 472 ATM kinase inhibitor Cell cycle; Genome integrity CP466722 GDSC.152 BRD-K15592317 COc1cc2ncnc(-n3nc(nc3N)-c3ccccn3)c2cc1OC ATM 472 ATM kinase inhibitor Cell cycle; Genome integrity KU-55933 CTRP.296;GDSC.1030 BRD-K25311561 O=c1cc(oc(c1)-c1cccc2Sc3ccccc3Sc12)N1CCOCC1 ATM;PRKDC 472;5591 ATM kinase inhibitor Cell cycle; Genome integrity OLIGOMYCIN A CTRP.386 BRD-A81541225 CCC1CCC2OC3(CC[C@@H](C)C(C[C@H](C)O)O3)[C@H](C)C(OC(=O)\C=C\[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C\1)[C@H]2C ATP5F1A 498 ATP synthase inhibitor; ATPase inhibitor ATPase inhibitor OUABAIN CTRP.388 BRD-K35708212 C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C2=CC(=O)OC2)[C@H](O)[C@H](O)[C@H]1O ATP1A1 476 ATPase inhibitor ATPase inhibitor DBEQ CTRP.209 BRD-K59204667 C(Nc1nc(NCc2ccccc2)c2ccccc2n1)c1ccccc1 CASP3 836 ATPase inhibitor ATPase inhibitor BLEBBISTATIN CTRP.155 BRD-A75817871 Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c1ccccc1 MYH2 4620 ATPase inhibitor ATPase inhibitor THAPSIGARGIN GDSC.180;gCSI.15 BRD-K69023402;BRD-A62809825 CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)/C(=CC)/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(=O)C)[C@@H]12)OC(=O)CCC)C ATP2A1 487 ATPase inhibitor; calcium channel blocker; PKC activator ATPase inhibitor ISOEVODIAMINE CTRP.276 BRD-A68631409 CN1C2N(CCc3c2[nH]c2ccccc32)C(=O)c2ccccc12 TRPV1 7442 ATPase inhibitor; TRPV agonist ATPase inhibitor ETP-46464 CTRP.224 BRD-K24556407 CC(C)(C#N)c1ccc(cc1)N1C(=O)OCc2cnc3ccc(cc3c12)-c1cnc2ccccc2c1 ATR kinase inhibitor Cell cycle; Genome integrity ALISERTIB CTRP.31 BRD-K75295174 COc1cc(Nc2ncc3CN=C(c4cc(Cl)ccc4-c3n2)c2c(F)cccc2OC)ccc1C(O)=O AURKA 6790 Aurora kinase inhibitor Mitosis GENENTECH CPD 10 GDSC.225 AURKA;AURKB 6790;9212 Aurora kinase inhibitor Mitosis ZM447439 GDSC.1050 BRD-K72703948 COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5 AURKA;AURKB 6790;9212 Aurora kinase inhibitor Mitosis GSK1070916 GDSC.226 BRD-K36740062 CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC(=CC=C5)CN(C)C AURKA;AURKB;AURKC;CYP2D6;CYP3A4 6790;9212;6795;1565;1576 Aurora kinase inhibitor Mitosis BARASERTIB CTRP.147 BRD-K63923597 CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1 AURKB 9212 Aurora kinase inhibitor Mitosis VX-680 CTRP.527;GDSC.32 BRD-K59369769 CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1 AURKA;AURKB;AURKC;LCK 6790;9212;6795;3932 Aurora kinase inhibitor; Bcr-Abl kinase inhibitor; FLT3 inhibitor; JAK inhibitor Mitosis STF-62247 GDSC.258 BRD-K85479953 Cc1cccc(Nc2nc(cs2)c3ccncc3)c1 autophagy inducer Other R428 CTRP.433 BRD-K14870255 Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1 AXL 558 AXL kinase inhibitor "Other, kinases" TIGECYCLINE CTRP.509 BRD-A34462049 CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3C(=O)[C@]2(O)C(=O)C(C(N)=O)C1=O)N(C)C bacterial 30S ribosomal subunit inhibitor Other EPIGALLOCATECHIN-3-MONOGALLATE CTRP.227 BRD-K55591206 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c1cc(O)c(O)c(O)c1 ELANE;EP300;FASN;KAT2B;MMP14;MMP2 1991;2033;2194;8850;4323;4313 bacterial DNA gyrase inhibitor Other BRD-K07442505 CTRP.66 BRD-K07442505 CCOc1ccccc1N\N=C1C(=O)N(N=C\1C)c1nc(cs1)-c1ccccc1 BAX 581 BAX activator Other ABT-199 CTRP.9 BRD-K62391742 CC1(C)CCC(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(NCC4CCOCC4)c(c3)[N+]([O-])=O)c(Oc3cnc4[nH]ccc4c3)c2)=C(C1)c1ccc(Cl)cc1 BCL2 596 BCL inhibitor Apoptosis regulation OBATOCLAX-MESYLATE CTRP.385 BRD-K15600710 COC1=CC(=N\C\1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1 BCL2 596 BCL inhibitor Apoptosis regulation OBATOCLAX MESYLATE GDSC.182 BRD-K15600710 BCL2 596 BCL inhibitor Apoptosis regulation ABT-263 CTRP.10;GDSC.1011 BRD-K82746043 CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1 BCL2;BCL2L1;BCL2L2 596;598;599 BCL inhibitor Apoptosis regulation ABT-737 CTRP.11 BRD-K56301217 CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1 BCL2;BCL2L1;BCL2L2 596;598;599 BCL inhibitor Apoptosis regulation TW-37 CTRP.497;GDSC.1149 BRD-K28360340 CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O BCL2;BCL2L1;MCL1 596;598;4170 BCL inhibitor Apoptosis regulation GOSSYPOL CTRP.260 BRD-K19295594 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O BCL2 596 BCL inhibitor; MCL1 inhibitor Apoptosis regulation GNF-2 GDSC.52 BRD-K97056771 C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F ABL1;BCR 25;613 Bcr-Abl kinase inhibitor ABL and/or SRC signaling DASATINIB CTRP.213;GDSC.51 BRD-K49328571 Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1 ABL1;ABL2;BLK;EPHA2;FGR;FRK;FYN;HCK;KIT;LCK;LYN;PDGFRB;SRC;SRMS;STAT5B;YES1 25;27;640;1969;2268;2444;2534;3055;3815;3932;4067;5159;6714;6725;6777;7525 Bcr-Abl kinase inhibitor; ephrin inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; src inhibitor; tyrosine kinase inhibitor ABL and/or SRC signaling PONATINIB GDSC.155 BRD-K44227013 CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 ABL1;BCR;FGFR1;FGFR2;FGFR3;FGFR4;FLT3;KDR;KIT;LCK;LYN;PDGFRA;RET;SRC;TEK 25;613;2260;2263;2261;2264;2322;3791;3815;3932;4067;5156;5979;6714;7010 Bcr-Abl kinase inhibitor; FLT3 inhibitor; PDGFR tyrosine kinase receptor inhibitor RTK signaling; ABL and/or SRC signaling IMATINIB CTRP.273;GDSC.34 BRD-K92723993 CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1 ABL1;CSF1R;DDR1;KIT;NTRK1;PDGFRA;PDGFRB;RET 25;1436;780;3815;4914;5156;5159;5979 Bcr-Abl kinase inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor ABL and/or SRC signaling KO-143 CTRP.301 BRD-K64642496 COc1ccc2c3C[C@@H]4N([C@@H](CC(C)C)c3[nH]c2c1)C(=O)[C@H](CCC(=O)OC(C)(C)C)NC4=O ABCB1;ABCC1 5243;4363 BCRP inhibitor Other MI-1 CTRP.315 BRD-K64497429 CC1(C)CN=C(S1)N1CCN(CC1)c1ncnc2sc3CCCCc3c12 MEN1 4221 binder of menin; inhibitor of menin-MLL fusion protein Other MI-2 CTRP.316 BRD-K90860366 CCCc1cc2c(ncnc2s1)N1CCN(CC1)C1=NCC(C)(C)S1 MEN1 4221 binder of menin; inhibitor of menin-MLL fusion protein Other 3-CL-AHPC CTRP.4 BRD-A09890259 OC(=O)\C=C\c1ccc(c(Cl)c1)-c1ccc(O)c(c1)C12C[C@H]3C[C@H](C[C@H](C3)C1)C2 NR0B2 8431 binder of nuclear receptor SHP Apoptosis regulation WZ-1-84 GDSC.59 BMX 660 BMX inhibitor Inhibitor of BMX and/or BTK QL-XII-61 GDSC.1203 CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CC=C(C=C5)NS(=O)(=O)C)NC(=O)C=C BMX;BTK 660;695 BMX inhibitor; Bruton's tyrosine kinase (BTK) inhibitor Inhibitor of BMX and/or BTK QL-XII-47 GDSC.235 BRD-U86922168 CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5 BMX;BTK 660;695 BMX inhibitor; Bruton's tyrosine kinase (BTK) inhibitor; cytoplasmic tyrosine protein kinase BMX inhibitor Inhibitor of BMX and/or BTK I-BET151 CTRP.265 BRD-K36363294 COc1cc2c3n([C@H](C)c4ccccn4)c(=O)[nH]c3cnc2cc1-c1c(C)noc1C BRD2;BRD3;BRD4 6046;8019;23476 bromodomain inhibitor Chromatin other GSK525762A CTRP.255;GDSC.275 BRD-K08109215 CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc12 BRD2;BRD3;BRD4 6046;8019;23476 bromodomain inhibitor Chromatin other PFI-1 GDSC.1219 BRD-K13094524 BRD4 23476 bromodomain inhibitor Chromatin other JQ-1 CTRP.282;GDSC.163;GDSC.1218 BRD-K54606188 Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)OC(C)(C)C)c1nnc(C)n-21)c1ccc(Cl)cc1 BRD4;BRDT 23476;676 bromodomain inhibitor Chromatin other IBRUTINIB CTRP.271 BRD-K70301465 Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C BLK;BMX;BTK 640;660;695 Bruton's tyrosine kinase (BTK) inhibitor Inhibitor of BMX and/or BTK LFM-A13 GDSC.192 BRD-A30655177 CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O BTK 695 Bruton's tyrosine kinase (BTK) inhibitor Inhibitor of BMX and/or BTK PHA-665752 GDSC.6;CCLE.4 BRD-K95435023 CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O MET 4233 c-Met inhibitor RTK signaling TACROLIMUS CTRP.499 BRD-K69608737 CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC FKBP1A 2280 calcineurin inhibitor Other CICLOSPORIN CTRP.194 BRD-A38030642 CCC1NC(=O)C([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C PPIA;ABCB11;CAMLG;CYP3A5;CYP3A7;FPR1;PPID;PPIF;PPP3CA;PPP3R2;SLC10A1;SLCO1B1;SLCO1B3 5478;8647;819;1577;1551;2357;5481;10105;5530;5535;6554;10599;28234 calcineurin inhibitor; cyclophilin inhibitor; immunosuppressant; insulin expression inhibitor; T cell inhibitor Other GW-405833 CTRP.256 BRD-K10705233 COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1 CNR2 1269 cannabinoid receptor agonist ERK MAPK signaling ETOMOXIR CTRP.232 BRD-K81335284 OC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1 CPT1A 1374 carnitine palmitoyltransferase inhibitor Other PF-4800567 HYDROCHLORIDE CTRP.395 BRD-K43428468 Nc1ncnc2n(nc(COc3cccc(Cl)c3)c12)C1CCOCC1 CSNK1D;CSNK1E 1453;1454 casein kinase inhibitor "Other, kinases" SILMITASERTIB CTRP.481 BRD-K81458380 OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21 CSNK2A1;CSNK2A2;DAPK3;HIPK3 1457;1459;1613;10114 casein kinase inhibitor "Other, kinases" COMPOUND 1541A CTRP.197 BRD-K30064966 Oc1cccc2cc(C(=O)Nc3cccc(c3)-c3cn4ccccc4n3)c(=O)oc12 CASP3 836 caspase activator Apoptosis regulation PAC-1 CTRP.409 BRD-K92991072 Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1 CASP3 836 caspase activator Apoptosis regulation PAC-1 GDSC.175 BRD-K92991072 Oc1c(CC=C)cccc1C=NNC(=O)CN2CCN(Cc3ccccc3)CC2 CASP3 836 caspase activator Apoptosis regulation BRD-K64610608 CTRP.113 BRD-K64610608 COc1ccc(cc1)S(=O)(=O)N(C)C[C@@H]1Oc2c(NC(=O)Nc3cccc4ccccc34)cccc2C(=O)N(C[C@H]1C)[C@@H](C)CO CASP3 836 caspase inhibitor Apoptosis regulation SID 26681509 CTRP.450 BRD-K08417745 CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C CTSL 1514 cathepsin inhibitor Protein stability and degradation SB-225002 CTRP.443 BRD-K61323504 Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O CXCR2 3579 CC chemokine receptor antagonist Other NSC95397 CTRP.357 BRD-K68143200 OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O CDC25A;CDC25B 993;994 CDC inhibitor Cell cycle KH-CB19 CTRP.291 BRD-K66430217 CCOC(=O)c1c(C(=CN)C#N)c2ccc(Cl)c(Cl)c2n1C CLK1;CLK3;DYRK1A 1195;1198;1859 CDC inhibitor Cell cycle INDISULAM CTRP.275 BRD-K17610631 NS(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1cccc2c(Cl)c[nH]c12 CA1;CA12;CA14;CA2;CA6;CA7;CA9 759;771;23632;760;765;766;768 CDK inhibitor Cell cycle RO-3306 GDSC.1052 BRD-K78373679 C1=CC2=C(C=CC(=C2)C=C3C(=O)N=C(S3)NCC4=CC=CS4)N=C1 CDK1 983 CDK inhibitor Cell cycle CGP-60474 GDSC.53 BRD-K79090631 C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO CDK1;CDK2 983;1017 CDK inhibitor Cell cycle ALVOCIDIB CTRP.33 BRD-K68682020 CN1CC[C@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl CDK1;CDK2;CDK4;CDK5;CDK6;CDK7;CDK8;CDK9;EGFR;PYGM 983;1017;1019;1020;1021;1022;1024;1025;1956;5837 CDK inhibitor Cell cycle AT-7519 GDSC.219 BRD-K13390322 Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1 CDK1;CDK2;CDK4;CDK5;CDK6;CDK9 983;1017;1019;1020;1021;1025 CDK inhibitor Cell cycle PHA-793887 CTRP.399;GDSC.301 BRD-K64800655 CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C CDK1;CDK2;CDK4;CDK5;CDK7;CDK9 983;1017;1019;1020;1022;1025 CDK inhibitor Cell cycle DINACICLIB CTRP.218 BRD-K13662825 CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO CDK1;CDK2;CDK5;CDK9 983;1017;1020;1025 CDK inhibitor Cell cycle N9-ISOPROPYLOLOMOUCINE CTRP.349 BRD-K71726959 CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc12 CDK1;CDK5 983;1020 CDK inhibitor Cell cycle SELICICLIB GDSC.110 BRD-K07691486 CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C CDK2;CDK9 1017;1025 CDK inhibitor Cell cycle CGP-082996 GDSC.54 CCNC1=NC(=NC(=C1)NC2CCC(CC2)O)NC3=CC4=C(C=C3)N(C=C4)CC5=CC=CC=C5 CDK4 1019 CDK inhibitor Cell cycle PALBOCICLIB GDSC.1054;CCLE.17 BRD-K51313569 CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C CDK4;CDK6 1019;1021 CDK inhibitor Cell cycle THZ-2-102-1 GDSC.346 CDK7 1022 CDK inhibitor Cell cycle THZ-2-49 GDSC.344 CDK9 1025 CDK inhibitor Cell cycle KIN001-270 GDSC.345 CDK9 1025 CDK inhibitor Cell cycle SNS-032 CTRP.455 BRD-K43389698 CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1 CDK2;CDK7;CDK9 1017;1022;1025 CDK inhibitor; cell cycle inhibitor; MCL1 inhibitor Cell cycle RIGOSERTIB CTRP.441 BRD-K55187425 COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1 PLK1 5347 cell cycle inhibitor; PLK inhibitor Cell cycle; PI3K/MTOR signaling NVP-231 CTRP.358 BRD-A12571627 O=C(Nc1nc2ccc(NC(=O)C34C[C@H]5C[C@H](C[C@H](C5)C3)C4)cc2s1)c1ccccc1 CERK 64781 ceramidase inhibitor "Other, kinases" PDMP CTRP.392 BRD-K05653692 CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c1ccccc1 ASAH1;UGCG 427;7357 ceramide glucosyltransferase inhibitor; glucosyltransferase inhibitor Metabolism; Cell cycle GW-2580 GDSC.193 BRD-K24242599 CSF1R 1436 cFMS kinase inhibitor RTK signaling AZD7762 CTRP.28;GDSC.1022 BRD-K86525559 NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1 CHEK1;CHEK2 1111;11200 CHK inhibitor Cell cycle NARCICLASINE CTRP.363 BRD-K06792661 O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O RHOA 387 coflilin signaling pathway activator; LIM kinase activator; ROCK activator Cell cycle; Mitosis VALDECOXIB CTRP.528 BRD-K12994359 Cc1onc(c1-c1ccc(cc1)S(N)(=O)=O)-c1ccccc1 CA12;PTGS2 771;5743 cyclooxygenase inhibitor Other HYPERFORIN CTRP.264 BRD-A30032852 CC(C)C(=O)[C@@]12C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C2=O NR1I2;ALOX5;PTGS1;TRPC6 8856;240;5742;7225 cyclooxygenase inhibitor; dopamine reuptake inhibitor; interleukin receptor antagonist; lipoxygenase inhibitor; serotonin uptake inhibitor Other CURCUMIN CTRP.204 BRD-K74148702 COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O APP;CA1;CA12;CA14;CA2;CA4;CA6;CA9;CYP3A4;DNMT3B;EP300;MMP13;MMP9;NOS2;PTGS1;PTGS2;XDH 351;759;771;23632;760;762;765;768;1576;1789;2033;4322;4318;4843;5742;5743;7498 cyclooxygenase inhibitor; histone acetyltransferase inhibitor; lipoxygenase inhibitor; NFkB pathway inhibitor Inducer of ROS; Modulator of NF-kappa-B signaling BAX-CHANNEL-BLOCKER CTRP.149 BRD-A18763547 OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12 BAX 581 cytochrome C release inhibitor Other ITRACONAZOLE CTRP.280 BRD-A34817987 CCC(C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OCC3COC(Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O CYP51A1 1595 cytochrome P450 inhibitor Hedgehog signaling AA-COCF3 CTRP.8 BRD-K07303502 CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)C(F)(F)F PLA2G4A 5321 cytosolic phospholipase inhibitor Metabolism QL-XI-92 GDSC.329 BRD-U73238814 CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3 DDR1 780 DDR1 inhibitor Other WP1130 CTRP.536 BRD-K43644456 CCC[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1 JAK2;UCHL5;USP14;USP9X 3717;51377;9097;8239 deubiquitinase inhibitor Protein stability and degradation SPAUTIN-1 CTRP.488 BRD-K84964099 Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1 USP10;USP13 9100;8975 deubiquitinase inhibitor Protein stability and degradation METHOTREXATE CTRP.343;GDSC.1008 BRD-K59456551 CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O DHFR 1719 dihydrofolate reductase inhibitor DNA replication PYRIMETHAMINE GDSC.71 BRD-K88429204 CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl DHFR;SLC47A1 1719;55244 dihydrofolate reductase inhibitor DNA replication PL-DI CTRP.402 BRD-K83336168 COc1cc(\C=C\C(=O)N2CCC=CC2=O)cc(OC)c1OCCN(C)CCOc1c(OC)cc(\C=C\C(=O)N2CCC=CC2=O)cc1OC dimer of piperlongumine; inducer of ROS Inducer of ROS SITAGLIPTIN CTRP.484 BRD-K19416115 N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F DPP4 1803 dipeptidyl peptidase inhibitor Metabolism CYCLOPHOSPHAMIDE CTRP.206 BRD-A09722536 ClCCN(CCCl)P1(=O)NCCCO1 CYP2A6;CYP2B6;CYP2C18;CYP2C19;CYP2C8;CYP2C9;CYP2D6;CYP3A4;CYP3A5;CYP3A7 1548;1555;1562;1557;1558;1559;1565;1576;1577;1551 DNA alkylating agent DNA replication IFOSFAMIDE CTRP.272 BRD-A67097164 ClCCNP1(=O)OCCCN1CCCl CYP2A6;CYP2B6;CYP2C18;CYP2C19;CYP2C8;CYP2C9;CYP3A4;CYP3A5;CYP3A7;PTGS1 1548;1555;1562;1557;1558;1559;1576;1577;1551;5742 DNA alkylating agent DNA replication TEMOZOLOMIDE CTRP.505;GDSC.1375 BRD-A94153989 CN1N=Nc2c(ncn2C1=O)C(=O)N MGMT 4255 DNA alkylating agent DNA replication DACARBAZINE CTRP.211 BRD-K35520305 CN(C)\N=N\c1[nH]cnc1C(N)=O PGD;POLA2 5226;23649 DNA alkylating agent DNA replication CARBOPLATIN CTRP.185 BRD-K11626735 O=C1O[Pt]OC(=O)C11CCC1 DNA alkylating agent; DNA inhibitor DNA replication PLATIN CTRP.423;GDSC.1005 BRD-K69172251 N[Pt](N)(Cl)Cl XIAP 331 DNA alkylating agent; DNA synthesis inhibitor DNA replication MITOMYCIN-C CTRP.345;GDSC.136 BRD-K59670716 CO[C@]12[C@H]3N[C@H]3CN1C1=C([C@H]2COC(N)=O)C(=O)C(N)=C(C)C1=O DNA alkylating agent; DNA synthesis inhibitor DNA replication NU7441 GDSC.1038 BRD-K00337317 C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56 PRKDC 5591 DNA dependent protein kinase inhibitor Genome integrity KU 0060648 CTRP.294 BRD-K09499853 CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c3oc(cc4=O)N3CCOCC3)c3sc4ccccc4c23)CC1 PIK3CA;PIK3CB;PIK3CD;PIK3CG;PRKDC 5290;5291;5293;5294;5591 DNA dependent protein kinase inhibitor; PI3K inhibitor Genome integrity CHLORAMBUCIL CTRP.192 BRD-K29458283 OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl DNA inhibitor DNA replication BENDAMUSTINE CTRP.151 BRD-K17068645 Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl DNA inhibitor DNA replication OXALIPLATIN CTRP.389 BRD-M14820059 O=C1O[Pt]2(NC3CCCCC3N2)OC1=O DNA inhibitor DNA replication ZEBULARINE CTRP.544 BRD-A01145011 OC[C@H]1O[C@H](C(O)[C@H]1O)n1cccnc1=O CDA;DNMT1 978;1786 DNA methyltransferase inhibitor Chromatin histone methylation TdCyd DNMT1 1786 DNA methyltransferase inhibitor Chromatin histone methylation AZACITIDINE CTRP.39 BRD-K03406345 Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 DNMT1;DNMT3A 1786;1788 DNA methyltransferase inhibitor Chromatin histone methylation DECITABINE CTRP.214 BRD-K79254416 Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 DNMT1;DNMT3A 1786;1788 DNA methyltransferase inhibitor Chromatin histone methylation RG-108 CTRP.435 BRD-K89391146 OC(=O)[C@H](Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O DNMT1;DNMT3B 1786;1789 DNA methyltransferase inhibitor Chromatin histone methylation NICLOSAMIDE CTRP.377 BRD-K35960502 Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O STAT3 6774 DNA replication inhibitor; STAT inhibitor Apoptosis regulation; Cell cycle BLEOMYCIN CTRP.156 BRD-A42083487 C[C@@H](O)[C@@H](NC(=O)[C@H](C)[C@@H](O)[C@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@@H](N)C(N)=O)C(O[C@H]1O[C@H](CO)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1)C(=O)NCCc1nc(cs1)-c1nc(cs1)C(=O)NCCC[S+](C)C LIG1;LIG3 3978;3980 DNA synthesis inhibitor DNA replication BLEOMYCIN GDSC.190;GDSC.1378 BRD-A42083487;BRD-A12918100 CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-] LIG1;LIG3 3978;3980 DNA synthesis inhibitor DNA replication NELARABINE CTRP.374 BRD-K84466663 COc1nc(N)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O POLA1 5422 DNA synthesis inhibitor; T cell inhibitor DNA replication TRIFLUOPERAZINE CTRP.518 BRD-K89732114 CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1 ADRA1A;CALM1;CALY;DRD2;DRD4;HRH1;HTR2A;HTR2C;S100A4;TNNC1 148;801;50632;1813;1815;3269;3356;3358;6275;7134 dopamine receptor antagonist Other PROCHLORPERAZINE CTRP.427 BRD-K19352500 CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1 DRD1;DRD2;DRD3;DRD4 1812;1813;1814;1815 dopamine receptor antagonist Other MDIVI-1 CTRP.341 BRD-K61128465 COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O DNM1 1759 dynamin inhibitor Other CUDC-101 GDSC.273 BRD-K41278234 EGFR;ERBB2 1956;2064 EGFR inhibitor Chromatin histone acetylation; EGFR signaling CANERTINIB CTRP.184 BRD-K50168500 Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl AKT1;EGFR;ERBB2;ERBB4 207;1956;2064;2066 EGFR inhibitor EGFR signaling CETUXIMAB GDSC.1114 EGFR 1956 EGFR inhibitor EGFR signaling WZ8040 CTRP.538 BRD-K81728688 CN1CCN(CC1)c1ccc(Nc2ncc(Cl)c(Sc3cccc(NC(=O)C=C)c3)n2)cc1 EGFR 1956 EGFR inhibitor EGFR signaling PELITINIB GDSC.282 BRD-K08799216 EGFR 1956 EGFR inhibitor EGFR signaling WZ4002 CTRP.537 BRD-K72420232 COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1 EGFR;ERBB2 1956;2064 EGFR inhibitor EGFR signaling LAPATINIB CTRP.307;GDSC.119;CCLE.5;gCSI.10 BRD-K19687926 CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1 EGFR;ERBB2 1956;2064 EGFR inhibitor EGFR signaling BIBW2992 CTRP.45 BRD-K66175015 CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1 EGFR;ERBB2;ERBB4 1956;2064;2066 EGFR inhibitor EGFR signaling AFATINIB GDSC.1032;GDSC.1377 BRD-K66175015 CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4 EGFR;ERBB2;ERBB4 1956;2064;2066 EGFR inhibitor EGFR signaling NERATINIB CTRP.376 BRD-K85606544 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C EGFR;ERBB2;KDR 1956;2064;3791 EGFR inhibitor EGFR signaling PD 153035 CTRP.390 BRD-K26603252 COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC EGFR;KDR 1956;3791 EGFR inhibitor EGFR signaling ERLOTINIB CTRP.230;GDSC.1;CCLE.24;gCSI.6 BRD-K70401845 COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC EGFR;NR1I2 1956;8856 EGFR inhibitor EGFR signaling GEFITINIB CTRP.258;GDSC.1010 BRD-K64052750 COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1 EGFR 1956 EGFR inhibitor EGFR signaling; PI3K/MTOR signaling WHI-P97 GDSC.288 BRD-K68407802 COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC EGFR;JAK3 1956;3718 EGFR inhibitor; JAK inhibitor; leukotriene synthesis inhibitor; mediator release inhibitor Apoptosis regulation; Cell cycle; EGFR signaling CP724714 GDSC.255 BRD-K76908866 COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1 ERBB2 2064 EGFR inhibitor; protein tyrosine kinase inhibitor EGFR signaling VANDETANIB CTRP.529;CCLE.10 BRD-K77625799 COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1 EGFR;EPHA1;EPHA10;EPHA2;EPHA3;EPHA4;EPHA5;EPHA6;EPHA7;EPHA8;EPHB1;EPHB2;EPHB3;EPHB4;EPHB6;ERBB2;ERBB3;ERBB4;FLT1;FLT4;KDR;PTK6;RET;SRC;TEK;VEGFA 1956;2041;284656;1969;2042;2043;2044;285220;2045;2046;2047;2048;2049;2050;2051;2064;2065;2066;2321;2324;3791;5753;5979;6714;7010;7422 EGFR inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor RTK signaling; EGFR signaling ZIBOTENTAN GDSC.266 BRD-K31553034 COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1 EDNRA 1909 endothelin receptor antagonist Other NVP-BHG712 GDSC.295 BRD-K79259477 EPHB4 2050 ephrin inhibitor Other FULVESTRANT CTRP.242 BRD-A85667082 C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31 ESR1;ESR2;GPER1 2099;2100;2852 estrogen receptor antagonist Hormone-related ML050 CTRP.322 BRD-A83255679 Brc1cc2OCOc2cc1C1Nc2ccccc2C2C=CCC12 GPER1 2852 estrogen receptor antagonist Hormone-related TAMOXIFEN CTRP.501;GDSC.1199 BRD-K93754473 CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1 EBP;ESR1;ESR2;GPER1;PRKCA;PRKCB;PRKCD;PRKCE;PRKCG;PRKCI;PRKCQ;PRKCZ 10682;2099;2100;2852;5578;5579;5580;5581;5582;5584;5588;5590 estrogen receptor antagonist; selective estrogen receptor modulator (SERM) Hormone-related SALUBRINAL GDSC.111 BRD-A45107007 C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3 EIF2S1 1965 eukaryotic translation initiation factor inhibitor Other COMPOUND 7D-CIS CTRP.200 BRD-K61829047 CCOC(=O)\C=C/n1nnc(n1)-c1cccc(Cl)c1 XPO1 7514 exportin antagonist Cell cycle KPT185 CTRP.293 BRD-K71467466 COc1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)OC(C)C)n1 XPO1 7514 exportin antagonist Cell cycle PF-750 CTRP.398 BRD-K83213911 O=C(Nc1ccccc1)N1CCC(Cc2cnc3ccccc3c2)CC1 FAAH 2166 FAAH inhibitor Metabolism LY-2183240 CTRP.306 BRD-K37865504 CN(C)C(=O)n1nnnc1Cc1ccc(cc1)-c1ccccc1 FAAH 2166 FAAH inhibitor; FAAH reuptake inhibitor Metabolism FTI-277 GDSC.166 COC(=O)C(CCSC)NC(=O)C1=C(C=C(C=C1)NCC(CS)N)C2=CC=CC=C2 FNTA 2339 Farnesyl-transferase (FNTA) Farnesyltransferase inhibitor TIPIFARNIB-P2 BRD-K62965247 Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1 FNTA;FNTB 2339;2342 farnesyltransferase inhibitor Farnesyltransferase inhibitor TIPIFARNIB CTRP.510;GDSC.204 BRD-K63195589 Cn1cncc1[C@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1 FNTA;FNTB 2339;2342 farnesyltransferase inhibitor Farnesyltransferase inhibitor MANUMYCIN A CTRP.338 BRD-K78599730 CCCC[C@@H](C)\C=C(C)\C=C(/C)C(=O)NC1=C[C@@](O)(\C=C\C=C\C=C\C(=O)NC2C(=O)CCC2=O)[C@@H]2O[C@@H]2C1=O FNTA;IKBKB 2339;3551 farnesyltransferase inhibitor; NFkB pathway inhibitor; ras farnesyltransferase inhibitor Farnesyltransferase inhibitor; Modulator of NF-kappa-B signaling CERULENIN CTRP.190 BRD-K52075040 C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(N)=O FASN 2194 fatty acid synthase inhibitor Metabolism AZD4547 CTRP.25 BRD-K28392481 COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N3C[C@H](C)N[C@H](C)C3)n[nH]2)cc(OC)c1 FGFR1;FGFR2;FGFR3;FGFR4;IGF1R;KDR 2260;2263;2261;2264;3480;3791 FGFR inhibitor RTK signaling REGORAFENIB CTRP.439 BRD-K16730910 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1 ABL1;BRAF;DDR2;EPHA2;FGFR1;FGFR2;FLT1;FLT4;FRK;KDR;KIT;MAPK11;NTRK1;PDGFRA;PDGFRB;RAF1;RET;TEK 25;673;4921;1969;2260;2263;2321;2324;2444;3791;3815;5600;4914;5156;5159;5894;5979;7010 FGFR inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAF inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor RTK signaling LENVATINIB CTRP.308 BRD-K39974922 COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O FLT4;KDR 2324;3791 FGFR inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling NINTEDANIB CTRP.379 BRD-K49075727 COC(=O)c1ccc2c(NC(=O)\C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1 FGFR1;FGFR2;FGFR3;FGFR4;FLT1;FLT4;KDR;PDGFRA;PDGFRB 2260;2263;2261;2264;2321;2324;3791;5156;5159 FGFR inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling BRIVANIB CTRP.160 BRD-K28428262 C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C CYP3A4;FGFR1;FLT1;KCNH2;KDR 1576;2260;2321;3757;3791 FGFR inhibitor; VEGFR inhibitor RTK signaling PD173074 GDSC.1049 BRD-K97764662 CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C FGFR1;FGFR2;FGFR3;FGFR4;FLT1;FLT4;KDR;PDGFRA;PDGFRB 2260;2263;2261;2264;2321;2324;3791;5156;5159 FGFR inhibitor; VEGFR inhibitor RTK signaling QUIZARTINIB CTRP.432;GDSC.254 BRD-K93918653 CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1 CSF1R;FLT3;KIT;PDGFRA;PDGFRB;RET 1436;2322;3815;5156;5159;5979 FLT3 inhibitor RTK signaling LESTAURTINIB GDSC.1024 BRD-A27376179 FLT3;NTRK1 2322;4914 FLT3 inhibitor; growth factor receptor inhibitor; JAK inhibitor Cell cycle; RTK signaling TG-101348 CTRP.494;GDSC.306 BRD-K12502280 Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C BRD4;JAK1;JAK2;JAK3;TYK2 23476;3716;3717;3718;7297 FLT3 inhibitor; JAK inhibitor Apoptosis regulation; Cell cycle; RTK signaling TANDUTINIB CTRP.502 BRD-K89162000 COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1 CSF1R;FLT3;KIT;PDGFD;PDGFRB 1436;2322;3815;80310;5159 FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor RTK signaling AMUVATINIB GDSC.293 BRD-K66538826 KIT;MET 3815;4233 FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAD51 inhibitor; RET tyrosine kinase inhibitor RTK signaling SORAFENIB CTRP.486;GDSC.30;CCLE.12 BRD-K23984367 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1 BRAF;DDR2;FGFR1;FLT1;FLT3;FLT4;KDR;KIT;PDGFRB;RAF1;RET 673;4921;2260;2321;2322;2324;3791;3815;5159;5894;5979 FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RAF inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor RTK signaling SUNITINIB CTRP.491;GDSC.5 BRD-K42828737 CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C CSF1R;FGFR1;FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB;RET 1436;2260;2321;2322;2324;3791;3815;5156;5159;5979 FLT3 inhibitor; KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; RET tyrosine kinase inhibitor; VEGFR inhibitor RTK signaling MIDOSTAURIN GDSC.153 BRD-K13646352 CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC FLT3;PRKCG 2322;5582 FLT3 inhibitor; KIT inhibitor; PKC inhibitor RTK signaling PF-573228 CTRP.397 BRD-K79239947 CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1 PTK2 5747 focal adhesion kinase inhibitor Cytoskeleton PF-562271 GDSC.158 BRD-K99545815 CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C PTK2;PTK2B 5747;2185 focal adhesion kinase inhibitor Cytoskeleton WAY-362450 CTRP.535 BRD-K54640016 CC(C)OC(=O)C1=CN(CC(C)(C)c2c1[nH]c1ccccc21)C(=O)c1ccc(F)c(F)c1 NR1H4 9971 FXR agonist Other SEMAGACESTAT CTRP.478 BRD-K65592642 CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@H]1c2ccccc2CCN(C)C1=O PSEN1 5663 gamma secretase inhibitor Gamma-secretase RO4929097 CTRP.437 BRD-K22024824 CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2ccccc2NC1=O PSEN1 5663 gamma secretase inhibitor Gamma-secretase AVAGACESTAT GDSC.205;GDSC.1072 BRD-K83720053 C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl PSEN1 5663 gamma secretase inhibitor Gamma-secretase MK-0752 CTRP.317 BRD-K18850819 OC(=O)CC[C@H]1CC[C@@](CC1)(c1cc(F)ccc1F)S(=O)(=O)c1ccc(Cl)cc1 gamma secretase inhibitor Gamma-secretase Z-LLNLE-CHO GDSC.45 CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1 PSEN1;NCSTN;APH1A;PSENEN 5663;23385;51107;55851 gamma-secretase Inhibitor Gamma-secretase GANT-61 CTRP.244 BRD-K09485525 CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1 GLI1;GLI2 2735;2736 GLI antagonist Hedgehog signaling DEXAMETHASONE CTRP.217 BRD-A35108200 CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO ANXA1;NOS2;NR0B1;NR3C1;NR3C2 301;4843;190;2908;4306 glucocorticoid receptor agonist Other 16-BETA-BROMOANDROSTERONE CTRP.1 BRD-K98404142 C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1C[C@H](Br)C2=O G6PD 2539 glucose 6 phosphate dehydrogenase inhibitor; immunostimulant Other PIPERLONGUMINE CTRP.420;GDSC.1243 BRD-K24132293 COc1cc(cc(OC)c1OC)\C=C\C(=O)N1CCC=CC1=O glutathione transferase inhibitor Inducer of ROS SB216763 GDSC.1025 BRD-K59184148 Cn1cc(C2=C(C(=O)NC2=O)c3ccc(Cl)cc3Cl)c4ccccc14 CCNA2;CDK2;GSK3A;GSK3B 890;1017;2931;2932 glycogen synthase kinase inhibitor WNT signaling CHIR-99021 CTRP.172 BRD-K16189898 Cc1c[nH]c(n1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl CDK1;GSK3A;GSK3B;MAPK1 983;2931;2932;5594 glycogen synthase kinase inhibitor WNT signaling CHIR-99021 GDSC.154;GDSC.1241 BRD-K16189898 CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N CDK1;GSK3A;GSK3B;MAPK1 983;2931;2932;5594 glycogen synthase kinase inhibitor WNT signaling GSK-3 INHIBITOR IX CTRP.248 BRD-K04923131 O\N=C1/C(Nc2ccccc12)=C1/C(=O)Nc2cc(Br)ccc12 GSK3A;GSK3B;TYK2;JAK1;JAK2;JAK3;STAT3 2931;2932;7297;3716;3717;3718;6774 glycogen synthase kinase inhibitor; lipoxygenase inhibitor WNT signaling; Apoptosis regulation; Cell cycle GW441756 GDSC.1023 BRD-K41312087 Cn1cc(C=C2C(=O)Nc3cccnc23)c4ccccc14 NTRK1 4914 growth factor receptor inhibitor RTK signaling ISOLIQUIRITIGENIN CTRP.277 BRD-K33583600 Oc1ccc(cc1)\C=C\C(=O)c1ccc(O)cc1O GABBR1 2550 guanylate cyclase activator Other EMBELIN GDSC.172 BRD-K86727142 CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O XIAP 331 HCV inhibitor; XIAP inhibitor Apoptosis regulation TACEDINALINE CTRP.498 BRD-K52313696 CC(=O)Nc1ccc(cc1)C(=O)Nc1ccccc1N HDAC1 3065 HDAC inhibitor Chromatin histone acetylation AR-42 GDSC.272 BRD-K13167095 HDAC1 3065 HDAC inhibitor Chromatin histone acetylation BELINOSTAT CTRP.150;GDSC.274 BRD-K17743125 ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc1ccccc1 HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9 3065;83933;79885;3066;8841;9759;10014;10013;51564;55869;9734 HDAC inhibitor Chromatin histone acetylation APICIDIN CTRP.34 BRD-K64606589 CC[C@@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9 3065;83933;79885;3066;8841;9759;10014;10013;51564;55869;9734 HDAC inhibitor Chromatin histone acetylation VORINOSTAT CTRP.532;GDSC.1012;gCSI.16 BRD-K81418486 ONC(=O)CCCCCCC(=O)Nc1ccccc1 HDAC1;HDAC10;HDAC11;HDAC2;HDAC3;HDAC5;HDAC6;HDAC8;HDAC9 3065;83933;79885;3066;8841;10014;10013;55869;9734 HDAC inhibitor Chromatin histone acetylation BRD-K88742110 CTRP.126 BRD-K88742110 COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1 HDAC1;HDAC10;HDAC6;HDAC8 3065;83933;10013;55869 HDAC inhibitor Chromatin histone acetylation MERCK60 CTRP.342 BRD-K04466929 CC(=O)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1 HDAC1;HDAC2 3065;3066 HDAC inhibitor Chromatin histone acetylation JQ12 GDSC.164 HDAC1;HDAC2 3065;3066 HDAC inhibitor Chromatin histone acetylation DACINOSTAT GDSC.200 BRD-K56957086 C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO HDAC1;HDAC2;HDAC3;HDAC4;HDAC5;HDAC6;HDAC7;HDAC8;HDAC9 3065;3066;8841;9759;10014;10013;51564;55869;9734 HDAC inhibitor Chromatin histone acetylation PANOBINOSTAT CTRP.413;CCLE.11 BRD-K02130563 Cc1[nH]c2ccccc2c1CCNCc1ccc(\C=C\C(=O)NO)cc1 HDAC1;HDAC2;HDAC3;HDAC4;HDAC6;HDAC7;HDAC8;HDAC9 3065;3066;8841;9759;10013;51564;55869;9734 HDAC inhibitor Chromatin histone acetylation VNLG/124 GDSC.271 HDAC1;HDAC2;HDAC3;HDAC8;HDAC6;RARA;RARB;RARG 3065;3066;8841;55869;10013;5914;5915;5916 HDAC inhibitor Chromatin histone acetylation MS-275 CTRP.336;GDSC.88;gCSI.11 BRD-K77908580 Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1 HDAC1;HDAC2;HDAC3;HDAC9 3065;3066;8841;9734 HDAC inhibitor Chromatin histone acetylation BRD-K29313308 CTRP.86 BRD-K29313308 CC(=O)Nc1ccc(cc1)C(=O)Nc1ccc(F)cc1N HDAC3 8841 HDAC inhibitor Chromatin histone acetylation ISOX CTRP.268;GDSC.276 BRD-K69840642 CC(C)(C)OC(=O)Nc1ccc(cc1)-c1cc(no1)C(=O)NCCCCCCC(=O)NO HDAC6 10013 HDAC inhibitor Chromatin histone acetylation TUBASTATIN A CTRP.520;GDSC.265 BRD-K00627859 CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO HDAC6 10013 HDAC inhibitor Chromatin histone acetylation BRD-K85133207 CTRP.124 BRD-K85133207 CC(=O)N[C@H]1C[C@H](C1)C(=O)Nc1cc(ccc1N)-c1ccc(F)cc1 HDAC inhibitor Chromatin histone acetylation VISMODEGIB GDSC.1033 BRD-K44827188 CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl SMO 6608 hedgehog pathway inhibitor; smoothened receptor antagonist Hedgehog signaling SGX-523 CTRP.449 BRD-K19477839 Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4ncccc4c3)n2n1 MET 4233 hepatocyte growth factor receptor inhibitor RTK signaling SU11274 CTRP.463 BRD-K02965346 CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1 MET 4233 hepatocyte growth factor receptor inhibitor; tyrosine kinase inhibitor RTK signaling CIMETIDINE CTRP.195 BRD-K34157611 CN\C(NCCSCc1nc[nH]c1C)=N/C#N HRH2;SLC29A4;SLC47A1;SLC47A2 3274;222962;55244;146802 histamine receptor antagonist Other BRD8958 CTRP.141 BRD-K68548958 CC1=NN(C(=O)C\1=C\c1ccc(o1)-c1cc(C)c(C)cc1[N+]([O-])=O)c1ccc(cc1)C(O)=O EP300 2033 histone acetyltransferase inhibitor Other GSK-J4 CTRP.249 BRD-K98203492 CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1 KDM6A;KDM6B 7403;23135 histone lysine demethylase inhibitor Chromatin histone methylation UNC0638 CTRP.522;GDSC.245;GDSC.1236 BRD-K86856088 COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN1CCCC1)C1CCCCC1 EHMT1;EHMT2 79813;10919 histone lysine methyltransferase inhibitor Chromatin histone methylation BIX-01294 CTRP.47 BRD-K26818574 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N1CCCN(C)CC1 EHMT1;EHMT2 79813;10919 histone lysine methyltransferase inhibitor Chromatin histone methylation QW-BI-011 CTRP.431 BRD-K72264770 COC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c3ccccc3)nc2c1 EHMT2 10919 histone lysine methyltransferase inhibitor Chromatin histone methylation UNC0321 CTRP.521 BRD-K74236984 COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1OCCOCCN(C)C)N1CCCN(C)CC1 EHMT2 10919 histone lysine methyltransferase inhibitor Chromatin histone methylation SGC0946 GDSC.1264 BRD-K69577666 histone lysine methyltransferase inhibitor Chromatin histone methylation LOVASTATIN CTRP.312 BRD-A70155556 CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(O)=O)C12 HDAC2;HMGCR;ITGAL;NR1I2 3066;3156;3683;8856 HMGCR inhibitor Metabolism FLUVASTATIN CTRP.240 BRD-A52530402 CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)C(c2ccccc12)c1ccc(F)cc1 HMGCR 3156 HMGCR inhibitor Metabolism SIMVASTATIN CTRP.482 BRD-K22134346 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 HMGCR;ITGB2 3156;3689 HMGCR inhibitor Metabolism AT13387 CTRP.17 BRD-K58435339 CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O HSP90AA1 3320 HSP inhibitor Protein stability and degradation 17-AAG CTRP.2;GDSC.1026;CCLE.3 BRD-K81473043 CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O HSP90AA1 3320 HSP inhibitor Protein stability and degradation LUMINESPIB GDSC.194 CCNC(=O)C1=C(C(=C2C=C(C(=CC2=O)O)C(C)C)ON1)C3=CC=C(C=C3)CN4CCOCC4 HSP90AA1 3320 HSP inhibitor Protein stability and degradation CCT-018159 GDSC.1170 BRD-K65503129 CCC1=CC(=C2C(=C(NN2)C)C3=CC4=C(C=C3)OCCO4)C(=O)C=C1O HSP90AA1;HSP90AB1 3320;3326 HSP inhibitor Protein stability and degradation VER-155008 CTRP.525 BRD-K32330832 Nc1ncnc2n([C@@H]3O[C@H](COCc4ccc(cc4)C#N)[C@@H](O)[C@H]3O)c(NCc3ccc(Cl)c(Cl)c3)nc12 HSPA1A 3303 HSP inhibitor Protein stability and degradation PIFITHRIN-MU CTRP.419 BRD-K96799727 NS(=O)(=O)C#Cc1ccccc1 HSPA1A;TP53 3303;7157 HSP inhibitor Protein stability and degradation SNX-2112 CTRP.456;GDSC.328 BRD-K71281111 CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@H](O)CC3)c2)C(F)(F)F)C(=O)C1 HSP inhibitor Protein stability and degradation IOX2 GDSC.1230 BRD-K98251413 EGLN1;KDM2A;KDM5C 54583;22992;8242 hypoxia inducible factor inhibitor Other BMS-536924 CTRP.51 BRD-K34581968 Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1 AKT1;CCNE1;CDK2;CYP3A4;ERBB2;IGF1R;KDR;LCK;MAPK1;MET;PDGFRA;PDGFRB 207;898;1017;1576;2064;3480;3791;3932;5594;4233;5156;5159 IGF-1 inhibitor IGFR signaling BMS-536924 GDSC.62;GDSC.1091 BRD-K34581968 CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NCC(C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5 AKT1;CCNE1;CDK2;CYP3A4;ERBB2;IGF1R;KDR;LCK;MAPK1;MET;PDGFRA;PDGFRB 207;898;1017;1576;2064;3480;3791;3932;5594;4233;5156;5159 IGF-1 inhibitor IGFR signaling BMS-754807 CTRP.52 BRD-K13049116 C[C@]1(CCCN1c1nc(Nc2cc(n[nH]2)C2CC2)c2cccn2n1)C(=O)Nc1ccc(F)nc1 AKT1;IGF1R 207;3480 IGF-1 inhibitor IGFR signaling BMS-754807 GDSC.184 BRD-K13049116 CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F AKT1;IGF1R 207;3480 IGF-1 inhibitor IGFR signaling GSK1904529A GDSC.202 BRD-K04833372 CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F IGF1R;INSR 3480;3643 IGF-1 inhibitor; insulin growth factor receptor inhibitor IGFR signaling AEW541 CCLE.1 C1CN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6 IGF1R;INSR 3480;3643 IGF-1 inhibitor; insulin growth factor receptor inhibitor IGFR signaling BMS-345541 CTRP.50;GDSC.203 BRD-K13566078 Cc1cnc2c(NCCN)nc3ccc(C)cc3n12 CHUK;IKBKB 1147;3551 IKK inhibitor Modulator of NF-kappa-B signaling TPCA-1 CTRP.496;GDSC.305 BRD-K51575138 NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1 IKBKB 3551 IKK inhibitor Modulator of NF-kappa-B signaling KIN001-260 GDSC.290 IKBKB 3551 IKK inhibitor Modulator of NF-kappa-B signaling BX795 GDSC.1037 BRD-K47983010 CDK2;CHEK1;GSK3B;KDR;PDK1;PDPK1 1017;1111;2932;3791;5163;5170 IKK inhibitor Modulator of NF-kappa-B signaling; Mitosis FINGOLIMOD CTRP.239 BRD-K88025533 CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1 S1PR1;S1PR5 1901;53637 immunosuppressant; sphingosine phosphate receptor agonist Sphingosine 1-phosphate receptor modulator IMPORTAZOLE CTRP.274 BRD-A02481876 CC(Nc1nc(nc2ccccc12)N1CCCC1)c1ccccc1 KPNB1 3837 importin-beta transport receptor inhibitor Other BRD-K94991378 CTRP.129 BRD-K94991378 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c2ccccc2OCCO)[C@H]([C@H](OC3=O)c2ccccc2)c2ccccc2)C(=O)NCC=C)c2cc(ccc12)C#CCC(C(=O)OC)C(=O)OC inducer of ROS Inducer of ROS BRD-K71935468 CTRP.118 BRD-K71935468 COC(=O)C(CC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c3ccccc3OCCO)[C@@H]([C@@H](OC4=O)c3ccccc3)c3ccccc3)C(=O)N3CCN(CC3)c3ncccn3)c2c1)C(=O)OC inducer of ROS Inducer of ROS NPC-26 CTRP.350 BRD-K36852164 CCOC(=O)c1c(NC(=O)c2ccc(s2)[N+]([O-])=O)sc2c1CC(C)(C)NC2(C)C "induces cell death through a non-apoptotic, mitochondrial-dependent mechanism" Other LBW242 CCLE.15 CC(C(=O)NC(C1CCCCC1)C(=O)N2CCC3C2CN(CC3)CCC4=CC=CC=C4)NC XIAP;BIRC2;FLT3 331;329;2322 Inhibitor Apoptosis regulation VX-970 ATR 545 Inhibitor Cell cycle; Genome integrity EHT-1864 GDSC.1069 RAC1;RAC2;RAC3 5879;5880;5881 Inhibitor Cytoskeleton TL-1-85 GDSC.261 MAP3K7 6885 Inhibitor ERK MAPK signaling (5Z)-7-OXOZEAENOL GDSC.1242 MAP3K7 6885 Inhibitor ERK MAPK signaling NG-25 GDSC.260 MAP3K7;MAP4K2 6885;5871 Inhibitor ERK MAPK signaling KIN001-266 GDSC.291 CCN1CCC(CC1)n1cc(CNc2cc(Cl)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1 MAP3K8 1326 Inhibitor ERK MAPK signaling TL-2-105 GDSC.211 RAF1 5894 Inhibitor ERK MAPK signaling CMK GDSC.64 CC1=C(C=CC(=C1)O)Cl RPS6KA3 6197 Inhibitor ERK MAPK signaling SL0101 GDSC.1039 RPS6KA3;AURKB;PIM1;PIM3 6197;9212;5292;415116 Inhibitor ERK MAPK signaling; Mitosis DMOG GDSC.165 COC(=O)CNC(=O)C(=O)OC EGLN1;EGLN2;EGLN3 54583;112398;112399 Inhibitor Metabolism XMD14-99 GDSC.253 CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC ALK;CDK7;LTK 238;1022;4058 Inhibitor Other XMD11-85H GDSC.1158 CC(C)N1C(=O)CCN(C2=NC(=NC=C21)NC3=C(C=C(C=C3)C(=O)NC4CCN(CC4)C)OC)C5CCCC5 BRSK2;FLT4;MARK4;PRKCD;RET;SRPK1 9024;2324;57787;5580;5979;6732 Inhibitor Other CCT007093 GDSC.1067 C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3 PPM1D 8493 Inhibitor Other XMD15-27 GDSC.332 CAMK2A;CAMK2B;CAMK2D;CAMK2G 815;816;817;818 Inhibitor "Other, kinases" SHIKONIN GDSC.170 PKM 5315 Inhibitor "Other, kinases" LGK974 PORCN 64840 Inhibitor WNT signaling PALMOSTATIN B CTRP.411 BRD-K42137908 CCCCCCCCCC[C@H]1[C@H](CCc2ccc(OC)c(OC)c2)OC1=O LYPLA1 10434 inhibitor of acyl-protein thioesterase 1 Other BEC CTRP.42 BRD-K53792571 N[C@H](CSCCB(O)O)C(O)=O ARG1;ARG2 383;384 inhibitor of arginase I and II Other VAF-347 CTRP.524 BRD-K96335988 FC(F)(F)c1ccc(Nc2nccc(n2)-c2cccc(Cl)c2)cc1 AHR 196 inhibitor of aryl hydrocarbon receptor Other SZ4TA2 CTRP.464 BRD-K55125219 CC1(C)CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(NCCSc2ccccc2)c(c1)[N+]([O-])=O BCL2L1 598 inhibitor of BCL-xL Apoptosis regulation BRD-M00053801 CTRP.135 BRD-M00053801 C[C@H](O)[C@@H]1[C@H](CO)ON(Cc2cccc(CN(CCN(C)C)[C@H](C3CCCCC3)c3ccccc3)c2)[C@@H]1C(=O)N[C@H]1C[C@H]2C[C@@H]([C@@H]1C)C2(C)C.C[C@H](O)[C@@H]1[C@H](CO)ON(Cc2cccc(CN(CCN(C)C)[C@@H](C3CCCCC3)c3ccccc3)c2)[C@@H]1C(=O)N[C@H]1C[C@H]2C[C@@H]([C@@H]1C)C2(C)C BCL2 596 inhibitor of BCL2 Apoptosis regulation BCL-LZH-4 CTRP.41 BRD-A68258842 COc1ccc(cc1)C1C(C(=O)Nc2ccccc2)=C(C)N=c2s\c(=C/c3cn(Cc4ccccc4)c4ccccc34)c(=O)n12 BCL2;BCL2L1;MCL1 596;598;4170 "inhibitor of BCL2, BCL-xL, and MCL1" Apoptosis regulation ML258 CTRP.328 BRD-A82720512 COc1ccc(CN2c3nnnn3C3C(C2=O)C2(CCCC2)Cc2ccccc32)cc1 BCL2L10 10017 inhibitor of BIM-BCL-B interaction Apoptosis regulation ML239 CTRP.327 BRD-K01121114 Clc1cc(Cl)c(OCC(=O)N\N=C\c2ccc[nH]2)c(Cl)c1 inhibitor of breast cancer stem cell proliferation Other BRD-K30748066 CTRP.88 BRD-K30748066 Cc1c(sc(=O)n1C)-c1ccnc(Nc2ccc(cc2)N2CCNCC2)n1 CDK9 1025 inhibitor of CDK9 Cell cycle NEOPELTOLIDE CTRP.375 BRD-K62479592 CCC[C@H]1C[C@H](C[C@H](C)C[C@@H]2C[C@H](C[C@H](CC(=O)O1)O2)OC(=O)\C=C/CCc1coc(\C=C/CNC(=O)OC)n1)OC inhibitor of cellular respiration Other CERANIB-2 CTRP.189 BRD-K31514534 COc1ccc(\C=C\C(=O)c2c(-c3ccccc3)c3ccccc3[nH]c2=O)cc1 ACER1;ACER2;ACER3;ASAH1;ASAH2;ASAH2B 125981;340485;55331;427;56624;653308 inhibitor of ceramidase activity Other FUMONISIN B1 CTRP.243 BRD-A63646118 CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(O)=O)C(O)=O)[C@H](CC(C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(O)=O)C(O)=O CERS1;CERS2;CERS3;CERS4;CERS5;CERS6 10715;29956;204219;79603;91012;253782 inhibitor of ceramide synthase Other PITSTOP2 CTRP.422 BRD-K90570971 Brc1ccc(cc1)\C=C1/SC(NS(=O)(=O)c2cccc3ccccc23)=NC1=O CLTA;CLTB;CLTC;CLTCL1 1211;1212;1213;8218 inhibitor of clathrin and clathrin-independent endocytosis Other NECROSULFONAMIDE CTRP.373 BRD-K64117221 COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)\C=C\c2ccc(s2)[N+]([O-])=O)cc1 MLKL 197259 inhibitor of downstream signaling of RIP3 associated with MLKL Necroptosis inhibition SMER-3 CTRP.453 BRD-K92960067 O=C1c2ccccc2-c2nc3nonc3nc12 CUL1;SKP1 8454;6500 inhibitor of E3-ubiquitin ligase Protein stability and degradation BRD-K51831558 CTRP.106 BRD-K51831558 CC(C)n1ncc2c(cc(Br)cc12)C(=O)NCc1c(C)cc(C)[nH]c1=O EZH2 2146 inhibitor of enhancer of zeste polycomb repressive complex 2 subunit Chromatin histone methylation BRD-K42260513 CTRP.98 BRD-K42260513 CC(C)n1ncc2c(cc(cc12)-c1ccc(nc1)N1CCNCC1)C(=O)NCc1c(C)cc(C)[nH]c1=O EZH2 2146 inhibitor of enhancer of zeste polycomb repressive complex 2 subunit Chromatin histone methylation BRD1835 CTRP.137 BRD-K62801835 C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(O)=O)Oc2cc(ccc2S1(=O)=O)C#CCC1CCCC1 EZH2 2146 inhibitor of enhancer of zeste polycomb repressive complex 2 subunit Chromatin histone methylation LEPTOMYCIN B CTRP.309 BRD-K27624156 CCC(\C=C\[C@@H]1OC(=O)C=C[C@@H]1C)=C\[C@H](C)C\C=C\C(C)=C\[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C\C(C)=C\C(O)=O XPO1 7514 inhibitor of exportin 1 Cell cycle L-685458 CTRP.302;CCLE.9 BRD-K87317732 CC(C)C[C@H](NC(=O)[C@@H](C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O APH1A;NCSTN;PSEN1;PSENEN 51107;23385;5663;55851 inhibitor of gamma-secretase Gamma-secretase C6-CERAMIDE CTRP.161 BRD-K08608874 CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCC MAPK1;PPP2CA;UGCG 5594;5515;7357 inhibitor of glucosylceramide synthase; activator of MAP kinase (ERK); stimulator of protein phosphatase 2A ERK MAPK signaling 968 CTRP.6 BRD-A43210826 CN(C)c1ccc(cc1Br)C1Nc2ccc3ccccc3c2C2=C1C(=O)CC(C)(C)C2 GLS 2744 inhibitor of glutaminase Metabolism ML320 CTRP.331 BRD-K81491172 COc1ccccc1[C@H]1c2c(NC3=C1C(=O)CC(C)(C)C3)n[nH]c2C(F)(F)F GSK3B 2932 inhibitor of GSK3 beta WNT signaling BRD-K24690302 CTRP.78 BRD-K24690302 CN(C)CC1CN(C1)C(=O)Nc1cc(ccc1N)-c1ccc(F)cc1 HDAC1 3065 inhibitor of HDAC1 Chromatin histone acetylation BRD-K80183349 CTRP.122 BRD-K80183349 CC(=O)N1CCC(CC1)C(=O)Nc1cc(ccc1N)-c1cccs1 HDAC1;HDAC2 3065;3066 inhibitor of HDAC1 and HDAC2 Chromatin histone acetylation BRD-K66532283 CTRP.115 BRD-K66532283 Nc1ccc(cc1NC(=O)C1=CCCC1)-c1cccs1 HDAC1;HDAC2 3065;3066 inhibitor of HDAC1 and HDAC2 Chromatin histone acetylation BRD-K11533227 CTRP.69 BRD-K11533227 CC(=O)NC1CCN(CC1)C(=O)Nc1cc(ccc1N)-c1cccs1 HDAC1;HDAC2 3065;3066 inhibitor of HDAC1 and HDAC2 Chromatin histone acetylation BRD-K61166597 CTRP.111 BRD-K61166597 Nc1ccc(cc1NC(=O)c1ccc(cc1)C(=O)NCCc1ccncc1)-c1cccs1 HDAC1;HDAC2 3065;3066 inhibitor of HDAC1 and HDAC2 Chromatin histone acetylation BRD-A94377914 CTRP.59 BRD-A94377914 CN1CCCCC1NC(=O)[C@H](CCCCCC(C)=O)C(=O)Nc1nc(cs1)-c1ccccc1 HDAC1;HDAC2;HDAC3;HDAC6;HDAC8 3065;3066;8841;10013;55869 "inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and HDAC8" Chromatin histone acetylation PANDACOSTAT CTRP.412 BRD-K44741158 ONC(=O)\C=C\c1ccc(cc1)C(=O)N\N=C\c1ccc(O)c(O)c1O HDAC1;HDAC2;HDAC3;HDAC6;HDAC8 3065;3066;8841;10013;55869 "inhibitor of HDAC1, HDAC2, HDAC3, HDAC6, and HDAC8" Chromatin histone acetylation REPLIGEN 136 CTRP.440 BRD-K47503321 Cc1ccc(cc1)C(=O)NCCCCCC(=O)Nc1ccc(F)cc1N HDAC3 8841 inhibitor of HDAC3 Chromatin histone acetylation ISONICOTINOHYDROXAMIC ACID CTRP.278 BRD-K55478147 ONC(=O)c1ccncc1 HDAC6 10013 inhibitor of HDAC6 Chromatin histone acetylation BRD-K51490254 CTRP.105 BRD-K51490254 ONC(=O)c1cccc(c1)C(=O)Nc1ccccc1 HDAC6;HDAC8 10013;55869 inhibitor of HDAC6 and HDAC8 Chromatin histone acetylation BRD-K28456706 CTRP.84 BRD-K28456706 Cc1c(oc2ccc3ccccc3c12)[N+]([O-])=O HNF4A 3172 inhibitor of hepatocyte nuclear factor 4 alpha Metabolism BRD-A02303741 CTRP.53 BRD-A02303741 CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H](C(O)[C@H]1O)n1cnc2c(N)ncnc12 DOT1L 84444 inhibitor of histone methyltransferases Chromatin histone methylation PF-184 CTRP.393 BRD-K11593101 C[C@@]1(CO)CN(C[C@]1(C)CO)c1cc(C(=O)Nc2ccc3CCc4c(nn(c4-c3c2)-c2ccc(F)cc2)C(N)=O)c(Cl)cn1 IKBKB 3551 inhibitor of IKK-2 Modulator of NF-kappa-B signaling CAY10576 CTRP.163;GDSC.91 BRD-K51781482 COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(s3)C#N)c2cc1OC IKBKE;TBK1;IKBKB 9641;29110;3551 inhibitor of IKK-epsilon Modulator of NF-kappa-B signaling ML334 DIASTEREOMER CTRP.332 BRD-K93367411 OC(=O)[C@@H]1CCCC[C@@H]1C(=O)N1CCc2ccccc2[C@H]1CN1C(=O)c2ccccc2C1=O KEAP1;NFE2L2 9817;4780 inhibitor of J405 protein-protein interaction Other MOMELOTINIB CTRP.346 BRD-K87737963 O=C(NCC#N)c1ccc(cc1)-c1ccnc(Nc2ccc(cc2)N2CCOCC2)n1 JAK1;JAK2 3716;3717 inhibitor of Janus kinases 1 and 2 Apoptosis regulation; Cell cycle ISPINESIB MESYLATE GDSC.208 KIF11 3832 Inhibitor ofÊkinesin spindle protein Mitosis BRD-K55116708 CTRP.108 BRD-K55116708 C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)Nc2ccccc2N)Oc2c(NC(=O)Nc3ccccc3)cccc2C1=O inhibitor of leukemic stem cells Other FQI-1 CTRP.236 BRD-A91658086 CCOc1ccccc1C1CC(=O)Nc2cc3OCOc3cc12 TFCP2 7024 inhibitor of LSF1-mediated transcription Other FQI-2 CTRP.237 BRD-K35498412 CCOc1ccccc1-c1cc(=O)[nH]c2cc3OCOc3cc12 TFCP2 7024 inhibitor of LSF1-mediated transcription Other METHYLSTAT CTRP.344 BRD-K52560704 COC(=O)\C=C\C(=O)N(O)CCCCNCc1ccc(COC(=O)Nc2cccc3ccccc23)cc1 KDM3A;KDM4A;KDM4B;KDM4C;KDM4D 55818;9682;23030;23081;55693 inhibitor of lysine specific demethylases Chromatin histone methylation CBB-1007 CTRP.166 BRD-K84754008 COC(=O)c1cc(CN2CCN(CC2)C(N)=N)cc(c1)C(=O)N1CCN(CC1)C(=O)c1ccc(cc1)C(N)=N KDM1A 23028 inhibitor of lysine-specific demethylase 1A (LSD1) Chromatin histone methylation CYANOQUINOLINE 11 CTRP.205 BRD-K00088062 Fc1ccc(Nc2c(cnc3c(Cl)cc(NCc4cnc[nH]4)cc23)C#N)cc1Cl MAP3K8 1326 inhibitor of MAP3K8; inhibitor of phosphorylated EGFR in cells ERK MAPK signaling; EGFR signaling ML311 CTRP.329 BRD-A40802033 CCN1CCN(CC1)C(c1ccc(cc1)C(F)(F)F)c1ccc2cccnc2c1O MCL1 4170 inhibitor of MCL1 Apoptosis regulation BRD-K35604418 CTRP.94 BRD-K35604418 Cc1cs\c(=N/C2CCCCC2)n1\N=C\c1ccc(O)c(O)c1O MCL1 4170 inhibitor of MCL1 Apoptosis regulation BRD-K79669418 CTRP.121 BRD-K79669418 CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@](C)(CCCCCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O MDM2;MDM4 4193;4194 inhibitor of MDM4-p53 interaction p53 pathway MYRICETIN CTRP.347 BRD-K43149758 Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O MAP2K1;PIK3CG 5604;5294 Inhibitor of MEK1 and PI3K ERK MAPK signaling; PI3K/MTOR signaling NECROSTATIN-7 CTRP.372 BRD-K50145167 Fc1ccc(cc1)-c1n[nH]cc1C=C1SC(=N)N(C1=O)c1nccs1 inhibitor of necroptosis Necroptosis inhibition FSC231 CTRP.238 BRD-K24784241 CCOC(=O)NC(=O)C(=C\c1ccc(Cl)c(Cl)c1)\C#N PICK1 9463 inhibitor of PDZ domain of protein interacting with PRKCA 1 (PICK1) "Other, kinases" TRIAZOLOTHIADIAZINE CTRP.517 BRD-K05402890 COc1ccc(OC)c(c1)-c1nnc2SCC(=Nn12)c1ccc(OC)c(OC)c1 PDE4A;PDE4B;PDE4D 5141;5142;5144 inhibitor of phosphdiesterase 4A/B/D Other VU0155056 CTRP.526 BRD-K31406481 O=C(NCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc2ccccc2c1 PLD1;PLD2 5337;5338 inhibitor of phospholipase D1/D2 Other CAY10594 CTRP.164 BRD-K61662457 O=C(NCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc2ccccc2c1 PLD2 5338 inhibitor of phospholipase D2 Other BRD-K70511574 CTRP.116 BRD-K62825658 COc1ccc(cc1)S(=O)(=O)N(C(=O)C)c2ccccc2C=Cc3cc[n+]([O-])cc3 PLK1 5347 inhibitor of polo-like kinase 1 (PLK1) Cell cycle B02 CTRP.40 BRD-K10882151 O=c1n(Cc2ccccc2)c(\C=C\c2cccnc2)nc2ccccc12 RAD51 5888 inhibitor of RAD51 Genome integrity ML312 CTRP.330 BRD-K70809902 CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)S(=O)(=O)c3ccc(Cl)cc3)[C@H](C)CN([C@H](C)CO)C(=O)c2c1 SCARB1 949 "inhibitor of scavenger receptor class B, member 1 (SCARB1)-mediated lipid uptake" Other JW-480 CTRP.288 BRD-K99655327 CC(C)c1ccccc1OC(=O)NCCc1ccc2ccccc2c1 NCEH1 57552 inhibitor of serine hydrolase enzyme NCEH Other SALERMIDE CTRP.465 BRD-A67788537 CC(C(=O)Nc1cccc(c1)\N=C\c1c(O)ccc2ccccc12)c1ccccc1 SIRT1;SIRT2 23411;22933 inhibitor of sirtuin 1 and sirtuin 2 Chromatin histone acetylation ML031 CTRP.321 BRD-K38985961 Cc1cc(C(=O)CN2C(=O)CCC2=O)c(C)n1Cc1ccccc1 S1PR2 9294 inhibitor of sphingosine 1-phosphate receptor 2 Sphingosine 1-phosphate receptor modulator CUCURBITACIN I CTRP.203 BRD-A28105619 CC(C)(O)\C=C\C(=O)[C@](C)(O)C1[C@H](O)C[C@@]2(C)C3CC=C4C(CC(=O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C JAK2;STAT3 3717;6774 inhibitor of STAT3/JAK2 signaling; JAK inhibitor; lipocortin synthesis stimulant; STAT inhibitor Apoptosis regulation; Cell cycle NSC30930 CTRP.354 BRD-K29711668 OC(=O)c1cc2cc(OCc3ccccc3)ccc2[nH]1 SRD5A2 6716 inhibitor of steroid 5-alpha reductase Hormone-related HBX-41108 CTRP.261 BRD-K50501969 Clc1ccc-2c(c1)C(=O)c1nc(C#N)c(nc-21)C#N USP7 7874 inhibitor of the deubiquitinase activity of USP7 Protein stability and degradation IPR-456 CTRP.267 BRD-A76527075 CC1CC(C)CN(C1)c1cc(Nc2ccccc2C(O)=O)c2C(=O)c3ccccc3-c3onc1c23 PLAUR 5329 inhibitor of the interaction of urokinase receptor with binding partners Other BAFILOMYCIN A1 CTRP.146 BRD-K86787118 CO[C@H]1\C=C\C=C(C)\C[C@@H](C)[C@H](O)[C@H](C)\C=C(C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@H]1C[C@@H](O)[C@H](C)[C@H](O1)C(C)C ATP6V0A1 535 inhibitor of the vacuolar-type H+-ATPase Other NSC48300 CTRP.355 BRD-K45748132 O[As](O)(=O)c1ccc(Cc2ccc(cc2)[As](O)(O)=O)cc1 TASP1 55617 inhibitor of threonine endopeptidase taspase 1 Other CHM-1 CTRP.173 BRD-K94145482 Fc1ccccc1-c1cc(=O)c2cc3OCOc3cc2[nH]1 inhibitor of tubulin polymerization Mitosis CCT036477 CTRP.167 BRD-A22997170 Cc1[nH]c2ccccc2c1C(Nc1ccccn1)c1ccc(Cl)cc1 inhibitor of WNT signaling by blocking beta-catenin transcription WNT signaling FGIN-1-27 CTRP.234 BRD-K09778810 CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1 TSPO 706 inositol monophosphatase inhibitor Other NVP-ADW742 CTRP.359 BRD-K15179513 Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@H]1C[C@H](CN2CCCC2)C1 IGF1R 3480 insulin growth factor receptor inhibitor IGFR signaling OSI-906 CTRP.383;GDSC.185 BRD-K08589866 CC1(O)CC(C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26 IGF1R;INSR;INSRR 3480;3643;3645 insulin growth factor receptor inhibitor; insulin receptor antagonist IGFR signaling ERASTIN CTRP.228 BRD-A25004090 CCOc1ccccc1-n1c(=O)c2ccccc2nc1C(C)N1CCN(CC1)C(=O)COc1ccc(Cl)cc1 VDAC2 7417 ion channel antagonist Metabolism BMS-509744 GDSC.63 BRD-A29901043 CC1=C(C=C(C(=C1)OC)C(=O)N2CCN(CC2)C(=O)C)SC3=CN=C(S3)NC(=O)C4=CC=C(C=C4)CNC(C)C(C)(C)C ITK 3702 ITK inhibitor Other AZD1480 CTRP.24 BRD-K65928735 C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1 JAK1;JAK2;JAK3 3716;3717;3718 JAK inhibitor Apoptosis regulation; Cell cycle RUXOLITINIB CTRP.442;GDSC.206 BRD-K53972329 N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12 JAK1;JAK2;JAK3;TYK2 3716;3717;3718;7297 JAK inhibitor Apoptosis regulation; Cell cycle NVP-BSK805 CTRP.361 BRD-K02017404 Fc1cc(cc(F)c1CN1CCOCC1)-c1cccc2ncc(nc12)-c1cnn(c1)C1CCNCC1 JAK2 3717 JAK inhibitor Apoptosis regulation; Cell cycle AS601245 GDSC.207 BRD-A60245366 C1=CC=C2C(=C1)NC(=C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4)S2 GSK3B;MAPK10;MAPK8;MAPK9;PIM1 2932;5602;5599;5601;5292 JNK inhibitor JNK and p38 signaling PYRAZOLANTHRONE CTRP.429 BRD-K01567962 O=C1c2ccccc2-c2n[nH]c3cccc1c23 MAPK10;MAPK8;MAPK8IP1;MAPK9;TTK 5602;5599;9479;5601;7272 JNK inhibitor JNK and p38 signaling JNK-9L GDSC.157 BRD-K19220233 N#Cc1cc(cc(c1)-c1ccnc(Nc2ccc(cc2)-n2cnc(n2)-c2cccnc2)n1)N1CCOCC1 MAPK8 5599 JNK inhibitor JNK and p38 signaling ZG-10 GDSC.1161 BRD-U51951544 CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4 MAPK8 5599 JNK inhibitor JNK and p38 signaling JNK INHIBITOR VIII GDSC.1043 MAPK8;MAPK9;MAPK10 5599;5601;5602 JNK inhibitor JNK and p38 signaling BRD9876 CTRP.143 BRD-K89329876 CC(C)(C)c1ccc2cc(C#N)c(cc2c1)C#N KIF11 3832 kinesin inhibitor Mitosis SB-743921 CTRP.446 BRD-K62358710 CC(C)[C@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1 KIF11 3832 kinesin-like spindle protein inhibitor Mitosis MASITINIB CTRP.340;GDSC.292 BRD-K71035033 CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1 FGFR3;KIT;PDGFRA;PDGFRB 2261;3815;5156;5159 KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; src inhibitor RTK signaling PAZOPANIB CTRP.416;GDSC.199 BRD-K74514084 CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1 CSF1R;FGF1;FGFR1;FGFR3;FLT1;FLT4;ITK;KDR;KIT;PDGFRA;PDGFRB;SH2B3 1436;2246;2260;2261;2321;2324;3702;3791;3815;5156;5159;10019 KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling MOTESANIB GDSC.1029 BRD-K99616396 CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C FLT1;FLT4;KDR;KIT 2321;2324;3791;3815 KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling KI8751 CTRP.300 BRD-K47150025 COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC KDR 3791 KIT inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling CEDIRANIB CTRP.188 BRD-K86930074 COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1 CSF1R;FLT1;FLT3;FLT4;KDR;KIT;PDGFRA;PDGFRB 1436;2321;2322;2324;3791;3815;5156;5159 KIT inhibitor; VEGFR inhibitor RTK signaling OSI-930 CTRP.384 BRD-K25340465 FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1 KDR;KIT 3791;3815 KIT inhibitor; VEGFR inhibitor RTK signaling OSI-930 GDSC.298 BRD-K25340465 FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1 KDR;KIT 3791;3815 KIT inhibitor; VEGFR inhibitor RTK signaling UNC1215 GDSC.1262 BRD-K83189926 L3MBTL3 84456 L3MBTL antagonist Chromatin other JW-7-24-1 GDSC.256 BRD-U68942961 COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC LCK 3932 LCK Inhibitor "Other, kinases" A-770041 GDSC.55 CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=C(C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)C(=NC=N4)N LCK;FYN 3932;2534 LCK Inhibitor "Other, kinases" LRRK2-IN-1 CTRP.304 BRD-K01436366 COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1 LRRK2 120892 leucine rich repeat kinase inhibitor "Other, kinases" XMD8-85 GDSC.106 BRD-K64857848 COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1 LRRK2;MAPK7 120892;5598 leucine rich repeat kinase inhibitor; MAP kinase inhibitor ERK MAPK signaling T0901317 GDSC.333 BRD-K23383398 OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c2ccccc2)(C(F)(F)F)C(F)(F)F NCOA1;NCOA2;NR1H2;NR1H3;NR1I2;RXRB 8648;10499;7376;10062;8856;6257 LXR agonist Other XMD8-92 GDSC.1164 BRD-K50387473 CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1 DCLK2;MAPK7;PLK4;TNK1 166614;5598;10733;8711 MAP kinase inhibitor ERK MAPK signaling VX-11E GDSC.262 BRD-K93725829 MAPK1 5594 MAP kinase inhibitor ERK MAPK signaling FR-180204 GDSC.263 BRD-K68756823 Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1 MAPK1;MAPK3 5594;5595 MAP kinase inhibitor ERK MAPK signaling HLI 373 CTRP.263 BRD-K17349619 CN(C)CCCNc1c2ccccc2n(C)c2nc(=O)n(C)c(=O)c12 MDM2 4193 MDM inhibitor p53 pathway RITA CTRP.436 BRD-K00317371 OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1 MDM2 4193 MDM inhibitor p53 pathway SERDEMETAN GDSC.1133 BRD-K65924316 C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4 MDM2 4193 MDM inhibitor p53 pathway NUTLIN-3 CTRP.380;GDSC.1047;CCLE.6 BRD-A12230535 COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1 MDM2;TP53 4193;7157 MDM inhibitor p53 pathway SJ-172550 CTRP.451 BRD-K93095519 CCOc1cc(cc(Cl)c1OCC(=O)OC)\C=C1C(=O)N(N=C/1C)c1ccccc1 MDM4 4194 MDM inhibitor p53 pathway NSC-207895 GDSC.269 MDM4 4194 MDM inhibitor p53 pathway JNJ-26854165 CTRP.281 BRD-K60219430 C(Cc1c[nH]c2ccccc12)Nc1cccc(Nc2ccncc2)c1 MDM2 4193 MDM inhibitor; angiogenesis stimulant; apoptosis stimulant p53 pathway AZD6244 CTRP.26;GDSC.1498;CCLE.19 BRD-K57080016 Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO MAP2K1 5604 MEK inhibitor ERK MAPK signaling PD318088 CTRP.391 BRD-A57798112 OCC(O)CONC(=O)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1F MAP2K1 5604 MEK inhibitor ERK MAPK signaling PD0325901 GDSC.1060;CCLE.16;gCSI.12 BRD-K49865102 C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O MAP2K1 5604 MEK inhibitor ERK MAPK signaling SELUMETINIB GDSC.1062 BRD-K57080016 CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO MAP2K1 5604 MEK inhibitor ERK MAPK signaling GSK1120212 CTRP.251;GDSC.1372 BRD-K12343256 CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O MAP2K1;MAP2K2 5604;5605 MEK inhibitor ERK MAPK signaling REFAMETINIB GDSC.1014;GDSC.1526 BRD-K85751432 COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F MAP2K1;MAP2K2 5604;5605 MEK inhibitor ERK MAPK signaling CI-1040 GDSC.1015 BRD-K05104363 C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl MAP2K1;MAP3K1;MAP3K2 5604;4214;10746 MEK inhibitor ERK MAPK signaling BIX02189 GDSC.279 BRD-K73368362 CN(C)Cc1cccc(NC(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1 MAP2K5;MAPK7 5607;5598 MEK inhibitor ERK MAPK signaling CICLOPIROX CTRP.193 BRD-K13044802 Cc1cc(C2CCCCC2)n(O)c(=O)c1 ATP1A1 476 membrane integrity inhibitor Other CYTOCHALASIN B CTRP.208 BRD-K26664453 C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]22OC(=O)\C=C\[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C ACTB 60 microtubule inhibitor Mitosis VINBLASTINE GDSC.1004 BRD-K06519765 CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O JUN;TUBA1A;TUBB;TUBD1;TUBE1;TUBG1 3725;7846;203068;51174;51175;7283 microtubule inhibitor; tubulin polymerization inhibitor Mitosis EPOTHILONE B GDSC.201 BRD-K68164687 TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA4A;TUBA8;TUBB;TUBB1;TUBB3;TUBB4A;TUBB4B 7846;10376;84790;7278;7277;51807;203068;81027;10381;10382;10383 microtubule stabilizing agent; tubulin polymerization inhibitor Mitosis S-TRITYL-L-CYSTEINE GDSC.41 BRD-K09774593 C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)[O-])[NH3+] mitotic kinesin inhibitor Mitosis CID-5951923 CTRP.175 BRD-A86956638 CN(C1CCS(=O)(=O)C1)C(=O)COC(=O)\C=C\c1cccc(c1)[N+]([O-])=O KLF5 688 modulator of KLF5 expression Other PROCARBAZINE CTRP.426 BRD-K13032584 CNNCc1ccc(cc1)C(=O)NC(C)C monoamine oxidase inhibitor DNA replication MPS-1-IN-1 GDSC.294 BRD-K94853001 TTK 7272 monopolar spindle 1 kinase inhibitor Mitosis AZ-3146 CTRP.20 BRD-K59146805 COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2n(C)c(=O)n(C3CCCC3)c2n1 monopolar spindle 1 kinase inhibitor Mitosis RAPAMYCIN CTRP.438;GDSC.3;gCSI.14 BRD-K84937637 CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O FGF2;FKBP1A;MTOR 2247;2280;2475 mTOR inhibitor PI3K/MTOR signaling JW-7-52-1 GDSC.83 [W].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W] MTOR 2475 mTOR inhibitor PI3K/MTOR signaling KU-0063794 CTRP.295 BRD-K67566344 COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1 MTOR 2475 mTOR inhibitor PI3K/MTOR signaling AZD8055 CTRP.29;GDSC.1059 BRD-K69932463 COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C MTOR 2475 mTOR inhibitor PI3K/MTOR signaling TEMSIROLIMUS CTRP.506;GDSC.1016 BRD-K08177763 CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO MTOR 2475 mTOR inhibitor PI3K/MTOR signaling OSI-027 CTRP.382 BRD-K87124298 COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12 MTOR 2475 mTOR inhibitor PI3K/MTOR signaling OSI-027 GDSC.299 BRD-K87124298 COc1cccc2cc([nH]c12)-c1nc([C@@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12 MTOR 2475 mTOR inhibitor PI3K/MTOR signaling Everolimus MTOR 2475 mTOR inhibitor PI3K/MTOR signaling QL-VIII-58 GDSC.1166 MTOR;ATR 2475;545 mTOR inhibitor PI3K/MTOR signaling QL-X-138 GDSC.331 BRD-U33728988 CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C BTK;JAK3;MKNK2;MTOR;PRKDC 695;3718;2872;2475;5591 mTOR inhibitor PI3K/MTOR signaling; Inhibitor of BMX and/or BTK NVP-BEZ235 CTRP.360;GDSC.1057 BRD-K12184916 Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1 ATR;MTOR;PIK3CA;PIK3CD;PIK3CG 545;2475;5290;5293;5294 mTOR inhibitor; PI3K inhibitor PI3K/MTOR signaling OMIPALISIB GDSC.283 BRD-K07972848 COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG 2475;5290;5291;5293;5294 mTOR inhibitor; PI3K inhibitor PI3K/MTOR signaling PI-103 CTRP.400;GDSC.302 BRD-K67868012 Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1 MTOR;PIK3CA;PIK3CB;PIK3CD;PIK3CG;PRKDC 2475;5290;5291;5293;5294;5591 mTOR inhibitor; PI3K inhibitor PI3K/MTOR signaling GMX-1778 CTRP.247 BRD-K47335880 Clc1ccc(OCCCCCC\N=C(\NC#N)Nc2ccncc2)cc1 NAMPT 10135 NAMPT inhibitor Metabolism CAY10618 CTRP.165 BRD-K83289131 O=C(CCCCCCCn1cc(nn1)-c1cccnc1)Nc1ccccc1-c1ccccc1 NAMPT 10135 NAMPT inhibitor Metabolism STF-31 CTRP.462 BRD-K22477529 CC(C)(C)c1ccc(cc1)S(=O)(=O)NCc1ccc(cc1)C(=O)Nc1cccnc1 NAMPT;SLC2A1 10135;6513 NAMPT inhibitor Metabolism AVICIN D CTRP.36 BRD-A15100685 CC1O[C@@H](OCC2O[C@@H](O[C@H]3CC[C@@]4(C)C(CC[C@]5(C)C4CC=C4C6CC(C)(C)[C@H](C[C@@]6([C@H](O)C[C@@]54C)C(=O)O[C@@H]4OC(CO)[C@@H](O)[C@@H](O)[C@@H]4O[C@@H]4OC(C)[C@H](O[C@@H]5O[C@@H](CO)[C@H](O)[C@@H]5O)[C@@H](O[C@@H]5OC(CO)[C@@H](O)[C@@H](O)[C@@H]5O)[C@@H]4O)OC(=O)C(\CO)=C\CC[C@](C)(O[C@@H]4OC(C)[C@@H](OC(=O)C(\CO)=C\CCC(C)(O)C=C)[C@@H](O)[C@@H]4O)C=C)C3(C)C)[C@@H](NC(C)=O)[C@H](O)[C@@H]2O)[C@@H](O[C@@H]2OC[C@@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H]1O natural product Other AUSTOCYSTIN D CTRP.35 BRD-K25987073 CC(C)(O)CCc1ccc(O)c2c1oc1cc3O[C@H]4OC=C[C@@]4(O)c3c(O)c1c2=O natural product; inducer of DNA damage DNA replication NAKITERPIOSIN CTRP.362 BRD-K38264551 C[C@H]1C[C@@H](OC1=O)[C@@H](O)[C@@H](C(Cl)Cl)c1ccc2[C@@H]3C[C@@H](Br)[C@]45O[C@H](C[C@]4(C)[C@H]3C(=O)c2c1C)CO[C@H]5O natural product; inhibitor of microtubule assembly Mitosis MARINOPYRROLE A CTRP.339 BRD-K57261999 Oc1ccccc1C(=O)c1[nH]c(Cl)c(Cl)c1-n1c(cc(Cl)c1Cl)C(=O)c1ccccc1O MCL1 4170 natural product; putative inhibitor of MCL1 Apoptosis regulation MLN4924 CTRP.335;GDSC.1529 BRD-K67844266 NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12 NAE1;UBA3 8883;9039 nedd activating enzyme inhibitor Other CHEMBL1222381 CTRP.170 BRD-K53903639 O=C(NC1CC1)c1cc(on1)-c1cccs1 NEUROD1 4760 neural stem cell inducer Other KHS101 CTRP.292 BRD-K78978711 CC(C)CNc1ccnc(NCc2csc(n2)-c2ccccc2)n1 TACC3 10460 neural stem cell inducer Other PARTHENOLIDE CTRP.415 BRD-K81651477 C\C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]2CC1 NFkB pathway inhibitor Chromatin histone acetylation; Inducer of ROS; Modulator of NF-kappa-B signaling PARTHENOLIDE GDSC.89 BRD-K98548675 CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C NFkB pathway inhibitor Chromatin histone acetylation; Modulator of NF-kappa-B signaling CHEMBL374350 CTRP.171 BRD-K59962020 Cc1cc2nc(NCCCO)n(CC(=O)c3cc(c(O)c(c3)C(C)(C)C)C(C)(C)C)c2cc1C NFkB pathway inhibitor Modulator of NF-kappa-B signaling BORTEZOMIB CTRP.157;GDSC.104;gCSI.2 BRD-K88510285 CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMA6;PSMA7;PSMA8;PSMB1;PSMB10;PSMB11;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMD1;PSMD2;RELA 5682;5683;5684;5685;5686;5687;5688;143471;5689;5699;122706;5690;5691;5692;5693;5694;5695;5696;5698;5707;5708;5970 NFkB pathway inhibitor; proteasome inhibitor Protein stability and degradation; Modulator of NF-kappa-B signaling FK866 CTRP.235;GDSC.1248 BRD-K58550667 O=C(NCCCCC1CCN(CC1)C(=O)c1ccccc1)\C=C\c1cccnc1 NAMPT 10135 niacinamide phosphoribosyltransferase inhibitor Metabolism BARDOXOLONE METHYL CTRP.148 BRD-K59437938 COC(=O)[C@@]12CCC(C)(C)C[C@@H]1[C@@H]1C(=O)C=C3[C@]4(C)C=C(C#N)C(=O)C(C)(C)[C@H]4CC[C@]3(C)[C@@]1(C)CC2 PPARG;STAT3 5468;6774 nuclear factor erythroid derived; like (NRF2) activator Other AVRAINVILLAMIDE CTRP.37 BRD-K10466330 CC1(C)Oc2ccc3C4=C[C@@]56NC(=O)[C@]7(CCCN7C5=O)C[C@H]6C(C)(C)C4=[N+]([O-])c3c2C=C1 nucleophosmin inhibitor Other LOMEGUATRIB CTRP.311 BRD-K27955832 Nc1nc(OCc2cc(Br)cs2)c2[nH]cnc2n1 MGMT 4255 O6-alkylguanine-DNA alkyltransferase inhibitor Chromatin histone methylation O-6-BENZYLGUANINE CTRP.381 BRD-K92041145 Nc1nc(OCc2ccccc2)c2[nH]cnc2n1 MGMT 4255 O6-alkylguanine-DNA alkyltransferase inhibitor Chromatin histone methylation ELESCLOMOL GDSC.1031 BRD-K82135108 CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2 HSPA1A 3303 oxidative stress inducer Protein stability and degradation IPA-3 GDSC.176 BRD-K38727704 C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O PAK1 5058 p21 activated kinase inhibitor Cytoskeleton PF-3758309 CTRP.394 BRD-K37764012 CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1 PAK4 10298 p21 activated kinase inhibitor Cytoskeleton BIRB-0796 CTRP.46 BRD-K74065929 Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C MAPK11;MAPK12;MAPK13;MAPK14 5600;6300;5603;1432 p38 MAPK inhibitor JNK and p38 signaling DORAMAPIMOD GDSC.1042 BRD-K74065929 MAPK11;MAPK12;MAPK13;MAPK14 5600;6300;5603;1432 p38 MAPK inhibitor JNK and p38 signaling VX-702 GDSC.1028 BRD-K07736136 C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F MAPK11;MAPK12;MAPK14 5600;6300;1432 p38 MAPK inhibitor JNK and p38 signaling SKEPINONE-L CTRP.485 BRD-K83607951 OC[C@@H](O)COc1ccc2CCc3cc(Nc4ccc(F)cc4F)ccc3C(=O)c2c1 MAPK14 1432 p38 MAPK inhibitor JNK and p38 signaling TAK-715 GDSC.221 BRD-K52751261 CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1 MAPK14 1432 p38 MAPK inhibitor JNK and p38 signaling AZD-2281 CTRP.21;GDSC.1017;GDSC.1495 BRD-K02113016 Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1 PARP1;PARP2 142;10038 PARP inhibitor Genome integrity RUCAPARIB GDSC.1175 BRD-K88560311 CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=CC(=CC(=C34)N2)F.OP(=O)(O)O PARP1;PARP2 142;10038 PARP inhibitor Genome integrity TALAZOPARIB GDSC.1259 BRD-K95142244 PARP2 10038 PARP inhibitor Genome integrity ABT-888 CTRP.12;GDSC.1018 BRD-K87142802 C[C@@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O PARP1;PARP2 142;10038 PARP inhibitor; DNA repair enzyme inhibitor Genome integrity LINIFANIB CTRP.310;GDSC.277 BRD-K99749624 Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1 CSF1;CSF1R;FLT1;FLT3;FLT4;KDR;KIT;PDGFRB;RET;TEK 1435;1436;2321;2322;2324;3791;3815;5159;5979;7010 PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling AXITINIB CTRP.38;GDSC.1021 BRD-K29905972 CNC(=O)c1ccccc1Sc1ccc2c(\C=C\c3ccccn3)n[nH]c2c1 CSF1;FLT1;FLT4;KDR;PLK4 1435;2321;2324;3791;10733 PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor RTK signaling TOSEDOSTAT CTRP.514 BRD-K92241597 CC(C)C[C@H]([C@H](O)C(=O)NO)C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1 ANPEP;LAP3;NPEPPS 290;51056;9520 peptidase inhibitor Other AS605240 GDSC.224 BRD-K41895714 O=C1NC(=O)C(S1)=C/c1ccc2nccnc2c1 MAOB;PIK3CA;PIK3CB;PIK3CD;PIK3CG 4129;5290;5291;5293;5294 Phosphatidylinositol 3-kinase (PI3K) inhibitor; PI3K inhibitor PI3K/MTOR signaling SILDENAFIL CTRP.480 BRD-K50128260 CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4 PDE5A;PDE6G;PDE6H;SLCO1B1;SLCO1B3 8654;5148;5149;10599;28234 phosphodiesterase inhibitor Other OSU-03012 GDSC.167 BRD-K90497590 C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F PDPK1 5170 phosphoinositide dependent kinase inhibitor PI3K/MTOR signaling KIN001-244 GDSC.287 BRD-K09186807 Fc1ccc(Cn2cccc(C(=O)N[C@@H](COc3ccc4[nH]c(=O)[nH]c4c3)c3ccccc3)c2=O)cc1F PDPK1 5170 phosphoinositide dependent kinase inhibitor PI3K/MTOR signaling XL765 CTRP.539 BRD-K75308783 COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1 MTOR;PIK3CG 2475;5294 PI3K inhibitor PI3K/MTOR signaling PIK-93 CTRP.401;GDSC.303 BRD-K29395450 CC(=O)Nc1nc(C)c(s1)-c1ccc(Cl)c(c1)S(=O)(=O)NCCO PI4KB;PIK3C3;PIK3CG 5298;5289;5294 PI3K inhibitor PI3K/MTOR signaling BYL-719 CTRP.145 BRD-K54997624 Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling GDC-0941 CTRP.246;GDSC.1058;GDSC.1527;gCSI.7 BRD-K52911425 CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling AZD6482 CTRP.27;GDSC.156;GDSC.1066 BRD-K58772419 C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1 PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling CAL-101 CTRP.162 BRD-K60866521 CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1 PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling TG-100-115 CTRP.493 BRD-K64785675 Nc1nc(N)c2nc(-c3cccc(O)c3)c(nc2n1)-c1cccc(O)c1 PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling IDELALISIB GDSC.238 BRD-K60866521 PIK3CA;PIK3CB;PIK3CD;PIK3CG 5290;5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling GSK2636771 CTRP.252 BRD-K49215523 Cc1nc2c(cc(cc2n1Cc1cccc(c1C)C(F)(F)F)N1CCOCC1)C(O)=O PIK3CB 5291 PI3K inhibitor PI3K/MTOR signaling TGX221 CTRP.495;GDSC.94 BRD-A41692738 CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1 PIK3CB;PIK3CD 5291;5293 PI3K inhibitor PI3K/MTOR signaling ZSTK474 CTRP.543;GDSC.223 BRD-K63068307 FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1 PIK3CB;PIK3CD;PIK3CG 5291;5293;5294 PI3K inhibitor PI3K/MTOR signaling IC-87114 CTRP.266 BRD-K75430629 Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc23)nc2cccc(C)c2c1=O PIK3CD 5293 PI3K inhibitor PI3K/MTOR signaling GSK1059615 CTRP.250 BRD-K06750613 O=C1NC(=O)\C(S1)=C\c1ccc2nccc(-c3ccncc3)c2c1 PIK3CG 5294 PI3K inhibitor PI3K/MTOR signaling YM201636 GDSC.310 BRD-K48488978 Nc1ccc(cn1)C(=O)Nc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1 PI3K inhibitor PI3K/MTOR signaling ENZASTAURIN GDSC.229 BRD-K79404599 AKT1;GSK3B;PRKCA;PRKCB;PRKCD;PRKCG 207;2932;5578;5579;5580;5582 PKC inhibitor PKC signaling SOTRASTAURIN CTRP.487 BRD-K16761703 CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1 PRKCA;PRKCB;PRKCD;PRKCE;PRKCH;PRKCQ 5578;5579;5580;5581;5583;5588 PKC inhibitor PKC signaling STAUROSPORINE CTRP.489 BRD-K17953061 CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 CDK2;GSK3B;CAMK2B;CDK1;CDK5;CHEK1;CHRM1;CHRM2;CHRM4;CSK;DAPK1;GPR35;IKBKB;ITK;LCK;LRRK2;MAP2K4;MAP2K6;MAPKAPK2;PAK2;PDPK1;PHKG2;PIK3CG;PIM1;PKN1;PRKACB;PRKCI;PRKCQ;RPS6KA1;STK3;SYK;TNIK;ZAP70 1017;2932;816;983;1020;1111;1128;1129;1132;1445;1612;2859;3551;3702;3932;120892;6416;5608;9261;5062;5170;5261;5294;5292;5585;5567;5584;5588;6195;6788;6850;23043;7535 PKC inhibitor; AKT inhibitor; BMX inhibitor; CDK inhibitor; CHK inhibitor; G protein coupled receptor agonist; glycogen synthase kinase inhibitor; leucine rich repeat kinase inhibitor; ribosomal protein inhibitor; sodium/hydrogen exchanger inhibitor Cell cycle BI-2536 CTRP.43;GDSC.60 BRD-K64890080 CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O BRD4;PLK1;PLK2;PLK3 23476;5347;10769;1263 PLK inhibitor Cell cycle GSK461364 CTRP.254 BRD-K92428232 C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F PLK1 5347 PLK inhibitor Cell cycle GW843682X CTRP.257;GDSC.87 BRD-K90382497 COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC PLK1;PLK3 5347;1263 PLK inhibitor Cell cycle NPK76-II-72-1 GDSC.257 CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C PLK3 1263 PLK inhibitor Cell cycle FH535 GDSC.173 BRD-K48112880 CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl PPARD;PPARG 5467;5468 PPAR receptor antagonist; WNT signaling inhibitor WNT signaling PRL-3 INHIBITOR I CTRP.406 BRD-K09907482 Brc1ccc(OCc2ccccc2Br)c(\C=C2\SC(=S)NC2=O)c1 PTP4A3 11156 PRL phosphatase inhibitor; tyrosine phosphatase inhibitor Other PLURIPOTIN CTRP.424 BRD-K98538768 CN1C(=O)N(Cc2cnc(Nc3cc(C)nn3C)nc12)c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C MAPK1;RASAL1 5594;8437 promoter of embryonic stem cell self-renewal; inhibitor of Ras-GAP and ERK ERK MAPK signaling MG-132 CTRP.313;GDSC.9 BRD-K60230970 CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O PSMB1 5689 proteasome inhibitor Protein stability and degradation MLN2238 CTRP.333 BRD-K78659596 CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O proteasome inhibitor Protein stability and degradation BRYOSTATIN 1 GDSC.197 BRD-K47405978 CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O PRKCE 5581 protein kinase C inhibitor PKC signaling HG-5-113-01 GDSC.1142 BRD-U82589721 CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=NC=C(C=C4)C(=O)NC ABL1;LTK;STK10 25;4058;6793 protein kinase inhibitor ABL and/or SRC signaling FMK GDSC.231 BRD-K24859147 RPS6KA3 6197 protein kinase inhibitor ERK MAPK signaling HG-5-88-01 GDSC.1143 BRD-U44700465 CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC(=C2Cl)N)NC3=C(C=C(C=C3)N4CCC(CC4)C(=O)N)OC COQ8B;EGFR 79934;1956 protein kinase inhibitor "Other, kinases" BREFELDIN A CTRP.159 BRD-A31107743 CC1CCC\C=C/C2CC(O)CC2C(O)\C=C/C(=O)O1 ARF1;CYTH2 375;9266 protein synthesis inhibitor Protein synthesis OMACETAXINE MEPESUCCINATE CTRP.387 BRD-K76674262 COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN3CCC[C@]23C=C1OC RPL3 6122 protein synthesis inhibitor Protein synthesis SCH-79797 CTRP.448 BRD-K17140735 CC(C)c1ccc(Cn2ccc3c2ccc2nc(NC4CC4)nc(N)c32)cc1 F2R 2149 proteinase activated receptor antagonist Other A-804598 CTRP.7 BRD-K76894955 C[C@H](\N=C(\NC#N)Nc1cccc2ncccc12)c1ccccc1 P2RX7 5027 purinergic receptor antagonist Other BRD-A71883111 CTRP.57 BRD-A71883111 Fc1cccc(c1)N(C(C(=O)NC1CCCCC1)c1ccccc1Cl)C(=O)Cc1cccs1 IDH1 3417 putative inhibitor of IDH1 R132H Other BRD-A05715709 CTRP.56 BRD-A05715709 Cc1ccccc1C(N(C(=O)Cc1ccncc1)c1cccc(F)c1)C(=O)NC1CCCCC1 IDH1 3417 putative inhibitor of IDH1 R132H Other BX-912 GDSC.222 BRD-K49669041 Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc4c[nH]cn4 CDK2;CHEK1;GSK3B;KDR;PDK1;PDPK1 1017;1111;2932;3791;5163;5170 pyruvate dehydrogenase kinase inhibitor "Other, kinases" AZD7545 CTRP.22 BRD-K52836380 CN(C)C(=O)c1ccc(cc1)S(=O)(=O)c1ccc(NC(=O)[C@@](C)(O)C(F)(F)F)c(Cl)c1 PDK1 5163 pyruvate dehydrogenase kinase inhibitor "Other, kinases" ML203 CTRP.325 BRD-K80672993 Nc1cccc(c1)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc2OCCOc2c1 PKM 5315 pyruvate kinase isozyme activator "Other, kinases" HG6-64-1 GDSC.159 BRAF 673 RAF inhibitor ERK MAPK signaling GDC-0879 CTRP.245 BRD-K67578145 OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CC\C2=N/O)c1 BRAF 673 RAF inhibitor ERK MAPK signaling SB590885 GDSC.1061 BRD-K78809024 CN(C)CCOC1=CC=C(C=C1)C2=NC(=C3C=CC4=C(CCC4=C3)N=O)C(=C5C=CNC=C5)N2 BRAF 673 RAF inhibitor ERK MAPK signaling PLX4720 CTRP.404;GDSC.1371;CCLE.20 BRD-K16478699 CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F BRAF;KDR 673;3791 RAF inhibitor ERK MAPK signaling PLX-4720 GDSC.1036 BRD-K16478699 CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F BRAF;KDR 673;3791 RAF inhibitor ERK MAPK signaling DABRAFENIB CTRP.210;GDSC.1373 BRD-K09951645 CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F BRAF;LIMK1;NEK11;RAF1;SIK1 673;3984;79858;5894;150094 RAF inhibitor ERK MAPK signaling PLX-4032 CTRP.403 BRD-K56343971 CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F BRAF;RAF1 673;5894 RAF inhibitor ERK MAPK signaling AZ628 GDSC.29 BRD-K05804044 CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(C)(C)C#N)NC3=CC4=C(C=C3)N=CN(C4=O)C BRAF;RAF1 673;5894 RAF inhibitor ERK MAPK signaling MLN2480 CTRP.334 BRD-K43410529 C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(s1)C(=O)Nc1cc(c(Cl)cn1)C(F)(F)F RAF inhibitor ERK MAPK signaling RAF265 CTRP.434;CCLE.21 BRD-K93123848 Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2cc(Oc3ccnc(c3)-c3ncc([nH]3)C(F)(F)F)ccc12 BRAF 673 RAF inhibitor; VEGFR inhibitor RTK signaling; ERK MAPK signaling NSC23766 CTRP.353 BRD-A80213327 CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1 Ras GTPase inhibitor Other CABOZANTINIB CTRP.183;GDSC.249 BRD-K51544265 COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC KDR;MET 3791;4233 RET tyrosine kinase inhibitor; VEGFR inhibitor RTK signaling AM-580 CTRP.15 BRD-K06854232 CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O RARA 5914 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator AC55649 CTRP.13 BRD-K93176058 CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O RARA;RARB 5914;5915 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator LE-135 CTRP.303 BRD-K06593056 CN1c2cc3c(cc2N=C(c2ccc(cc2)C(O)=O)c2ccccc12)C(C)(C)CCC3(C)C RARB 5915 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator CD-437 CTRP.169 BRD-K28907958 OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2 RARG 5916 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator CD-1530 CTRP.168 BRD-K25737009 OC(=O)c1ccc(cc1)-c1ccc2cc(c(O)cc2c1)C12CC3CC(CC(C3)C1)C2 RARG 5916 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator BEXAROTENE CTRP.153;GDSC.186 BRD-K92441787 Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C RXRA;RXRB;RXRG 6256;6257;6258 retinoid receptor agonist Retinoic acid receptor and retinoid X receptor modulator TRETINOIN GDSC.1009 BRD-K71879491 CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C ALDH1A1;ALDH1A2;GPRC5A;NR0B1;NR2C2;PPARD;RARA;RARB;RARG;RARRES1;RORB;RORC;RXRB;RXRG 216;8854;9052;190;7182;5467;5914;5915;5916;5918;6096;6097;6257;6258 retinoid receptor agonist; retinoid receptor ligand Retinoic acid receptor and retinoid X receptor modulator CH-55 CTRP.191 BRD-K71487808 CC(C)(C)c1cc(cc(c1)C(C)(C)C)C(=O)\C=C\c1ccc(cc1)C(O)=O RARA;RARB 5914;5915 retinoid receptor binder Retinoic acid receptor and retinoid X receptor modulator GSK429286A GDSC.230 BRD-A10523515 CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F ROCK1 6093 rho associated kinase inhibitor Cytoskeleton Y-39983 GDSC.309 BRD-K56751279 C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12 ROCK1;ROCK2 6093;9475 rho associated kinase inhibitor Cytoskeleton GSK269962A GDSC.127;GDSC.1192 CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6 ROCK1;ROCK2 6093;9475 rho associated kinase inhibitor Cytoskeleton GEMCITABINE CTRP.259;GDSC.135;gCSI.8 BRD-K15108141 Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1 CMPK1;RRM1;RRM2;TYMS 51727;6240;6241;7298 ribonucleotide reductase inhibitor DNA replication CYTARABINE CTRP.207 BRD-K33106058 Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1 POLA1;POLB;POLD1;POLE 5422;5423;5424;5426 ribonucleotide reductase inhibitor DNA replication CYTARABINE GDSC.1006 BRD-K71847383 C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl POLA1;POLB;POLD1;POLE 5422;5423;5424;5426 ribonucleotide reductase inhibitor DNA replication CLOFARABINE CTRP.196 BRD-K34022604 Nc1nc(Cl)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F POLA1;POLD1;POLE;RRM1;RRM2;RRM2B 5422;5424;5426;6240;6241;50484 ribonucleotide reductase inhibitor DNA replication BI-D1870 gCSI.1 BRD-A81370665 CC1C(=O)N(C2=CN=C(N=C2N1CCC(C)C)NC3=CC(=C(C(=C3)F)O)F)C RPS6KA1;RPS6KA2;RPS6KA3;RPS6KA6 6195;6196;6197;27330 ribosomal protein inhibitor Other PF-4708671 GDSC.1129 BRD-K14711741 CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F RPS6KB1 6198 ribosomal protein inhibitor Other NECROSTATIN-1 CTRP.371 BRD-A36318220 CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O RIPK1 8737 RIPK inhibitor Apoptosis regulation; Necroptosis inhibition XMD13-2 GDSC.330 C1CC1C(=O)NC2=NNC3=C2C=CC(=C3)C4=CC(=CC=C4)C(=O)NC5CC5 RIPK1 8737 RIPK inhibitor Apoptosis regulation; Necroptosis inhibition TRIPTOLIDE CTRP.519 BRD-A13122391 CC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3CC3C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O RELA 5970 RNA polymerase inhibitor Other CX-5461 GDSC.300 BRD-K12787259 RNA polymerase inhibitor Other ML162 CTRP.324 BRD-A36275421 COc1ccc(cc1Cl)N(C(C(=O)NCCc1ccccc1)c1cccs1)C(=O)CCl selectively kills engineered cells expressing mutant HRAS Other ML210 CTRP.326 BRD-K01877528 Cc1onc(C(=O)N2CCN(CC2)C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)c1[N+]([O-])=O selectively kills engineered cells expressing mutant HRAS Other BRD8899 CTRP.140 BRD-K22828899 CC(=O)NC[C@@H]1C[C@H](CN1)NS(=O)(=O)c1cccc2cncc(C)c12 serine/threonine kinase inhibitor ERK MAPK signaling GSK650394 GDSC.177 BRD-K14991967 C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O SGK1;SGK2 6446;10110 serum/glucocorticoid regulated kinase inhibitor Other NSC-87877 GDSC.147 C1=CC2=C(C(=O)C(=NNC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)C=C2S(=O)(=O)O)N=C1 PTPN6;PTPN11 5777;5781 "SHP-1 (PTPN6), SHP-2 (PTPN11)" Other SR-II-138A CTRP.458 BRD-K11172604 CON(C)C(=O)[C@H]1[C@@H](O)[C@@]2(O)c3c(O[C@]2([C@@H]1c1ccccc1)c1ccc(OC)cc1)cc(OC)cc3OC EIF4A2;EIF4E;EIF4G1 1974;1977;1981 silvestrol analog; inhibits translation by modulating the eIF4F complex Protein synthesis CR-1-31B CTRP.182 BRD-K23547378 CONC(=O)[C@H]1[C@@H](O)[C@@]2(O)c3c(O[C@]2([C@@H]1c1ccccc1)c1ccc(OC)cc1)cc(OC)cc3OC EIF4A2;EIF4E;EIF4G1 1974;1977;1981 silvestrol analog; inhibits translation by modulating the eIF4F complex Protein synthesis SRT-1720 CTRP.461 BRD-K53855319 O=C(Nc1cc(CN2CCNCC2)cc(c1)-c1nc2ccccc2[nH]1)c1cnc2ccccc2n1 SIRT1 23411 SIRT activator Chromatin histone acetylation EX-527 CTRP.225;GDSC.341 BRD-K76964878 NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21 SIRT1 23411 SIRT inhibitor Chromatin histone acetylation AGK-2 CTRP.14 BRD-K32536677 Clc1ccc(Cl)c(c1)-c1ccc(\C=C(/C#N)C(=O)Nc2cccc3ncccc23)o1 SIRT2 22933 SIRT inhibitor Chromatin histone acetylation AT-406 CTRP.16 BRD-K02834582 CNC(C)C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(c3ccccc3)c4ccccc4)C(=O)CC(C)C XIAP 331 SMAC mimetic; inhibitor of inhibitor of apoptosis proteins (IAPs) Apoptosis regulation PURMORPHAMINE CTRP.428 BRD-K73397362 C1CCC(CC1)n1cnc2c(Nc3ccc(cc3)N3CCOCC3)nc(Oc3cccc4ccccc34)nc12 SMO 6608 smoothened receptor agonist Hedgehog signaling ERISMODEGIB CTRP.229 BRD-K19796430 C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1 SMO 6608 smoothened receptor antagonist Hedgehog signaling CYCLOPAMINE GDSC.17 BRD-K58938839;BRD-A02333338 CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 SMO;DHH;IHH;PTCH1 6608;50846;3549;5727 smoothened receptor antagonist; hedgehog pathway inhibitor Hedgehog signaling PHLORETIN CTRP.417 BRD-K15563106 Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1 AQP9;CLCN3;SLC23A1 366;1182;9963 sodium/glucose cotransporter inhibitor Other MYRIOCIN CTRP.348 BRD-A76279427 CCCCCCC(=O)CCCCCC\C=C\C[C@H](O)[C@@H](O)C(N)(CO)C(O)=O AKT1;SPTLC1;SPTLC2;SPTLC3 207;10558;9517;55304 sphingolipid biosynthesis inhibitor Metabolism SKI-II CTRP.452 BRD-K20755323 Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1 SPHK1 8877 sphingosine kinase inhibitor "Other, kinases" PF-543 CTRP.396 BRD-K79877282 Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1 SPHK1 8877 sphingosine kinase inhibitor "Other, kinases" AZD0530 CTRP.23;GDSC.38;CCLE.7 BRD-K19540840 CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1 ABL1;LCK;SRC;YES1 25;3932;6714;7525 src inhibitor ABL and/or SRC signaling WH-4-023 GDSC.56 BRD-K50199947 CC1=C(C(=CC=C1)C)OC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(CC5)C LCK;SRC 3932;6714 src inhibitor ABL and/or SRC signaling WZ3105 GDSC.252 CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C SRC;ROCK2;NTRK2;FLT3;IRAK1 6714;9475;4915;2322;3654 src inhibitor ABL and/or SRC signaling KX2-391 CTRP.299 BRD-K29968218 O=C(Cc1ccc(cn1)-c1ccc(OCCN2CCOCC2)cc1)NCc1ccccc1 SRC 6714 src inhibitor; tubulin polymerization inhibitor ABL and/or SRC signaling YL54 CTRP.541 BRD-K58306044 CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCC\C=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O stapled helical peptide Other BRD-K20514654 CTRP.77 BRD-K20514654 CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@]1(C)CCC\C=C/CCC[C@@](C)(NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O stapled helical peptide Other BRD-K99584050 CTRP.134 BRD-K99584050 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O stapled helical peptide Other BRD-K03911514 CTRP.64 BRD-K03911514 CCCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O stapled helical peptide Other BRD-K16130065 CTRP.73 BRD-K16130065 CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O stapled helical peptide Other BRD-K58730230 CTRP.110 BRD-K58730230 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O stapled helical peptide Other BRD-K27188169 CTRP.80 BRD-K27188169 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O stapled helical peptide Other BRD-K13185470 CTRP.70 BRD-K13185470 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@]1(C)CCC\C=C/CCC[C@](C)(NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O MCL1 4170 stapled helical peptide targeting MCL1 Apoptosis regulation BRD-K55473186 CTRP.109 BRD-K57252013 CCC(C)C(NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CCNC(=O)C)C(=O)NC1(C)CCCC=CCCCC(C)(NC(=O)C(CCCNC(=N)N)NC(=O)C(CS)NC(=O)C(CC(C)C)NC1=O)C(=O)NC(Cc2c[nH]cn2)C(=O)NC(Cc3c[nH]cn3)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)N NOTCH1 4851 stapled helical peptide targeting NOTCH1 Other NSC-74859 CTRP.351 BRD-K40853697 Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1 STAT3 6774 STAT inhibitor Apoptosis regulation; Cell cycle YM-155 CTRP.542;GDSC.268 BRD-K76703230 COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C BIRC5 332 survivin inhibitor Apoptosis regulation TAMATINIB CTRP.500 BRD-K20285085 COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC RET;SYK 5979;6850 SYK inhibitor "Other, kinases" BAY-61-3606 GDSC.178 BRD-K53281329 SYK 6850 SYK inhibitor "Other, kinases" 1S-3R-RSL-3 CTRP.3 BRD-K23853216 COC(=O)[C@H]1Cc2c([nH]c3ccccc23)[C@@H](N1C(=O)CCl)c1ccc(cc1)C(=O)OC GPX4 2879 synthetic lethal with HRAS in engineered cells; inhibitor of GPX4 Other SR1001 CTRP.459 BRD-K47981327 CC(=O)Nc1nc(C)c(s1)S(=O)(=O)Nc1ccc(cc1)C(O)(C(F)(F)F)C(F)(F)F RORA;RORC 6095;6097 synthetic ROR ligand; suppressor of TH17 differentiation Hormone-related XAV939 GDSC.1268 BRD-K12762134 C1CSCC2=C1NC(=NC2=O)C3=CC=C(C=C3)C(F)(F)F TNKS;TNKS2 8658;80351 tankyrase inhibitor WNT signaling JW-55 CTRP.289 BRD-K53328210 COc1ccc(cc1)C1(CNC(=O)c2ccc(NC(=O)c3ccco3)cc2)CCOCC1 TNKS;TNKS2 8658;80351 tankyrase inhibitor WNT signaling; Telomere modulator MST-312 CTRP.337 BRD-K19894101 Oc1cccc(C(=O)Nc2cccc(NC(=O)c3cccc(O)c3O)c2)c1O TERT 7015 telomerase inhibitor Telomere modulator BIBR-1532 CTRP.44 BRD-K04623885 C\C(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1 TERT 7015 telomerase inhibitor Telomere modulator SB-431542 CTRP.444 BRD-K67298865 NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1 ACVR1C;TGFBR1 130399;7046 TGF beta receptor inhibitor RTK signaling SB-525334 CTRP.445;GDSC.304 BRD-K37720887 Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C TGFBR1 7046 TGF beta receptor inhibitor RTK signaling LY-2157299 CTRP.305 BRD-K78118466 Cc1cccc(n1)-c1nn2CCCc2c1-c1ccnc2ccc(cc12)C(N)=O TGFBR1 7046 TGF beta receptor inhibitor RTK signaling PX-12 CTRP.407 BRD-A56592690 CCC(C)SSc1ncc[nH]1 TXN;TXNRD1 7295;7296 thioredoxin inhibitor Other PRIMA-1-MET CTRP.405 BRD-K49456190 COC[C@]1(CO)[N@@]2CC[C@@H](CC2)C1=O TP53 7157 thioredoxin inhibitor; TP53 activator p53 pathway VORAPAXAR CTRP.531 BRD-K93442924 CCOC(=O)N[C@@H]1CC[C@@H]2[C@H](C[C@@H]3[C@@H]([C@@H](C)OC3=O)[C@H]2\C=C\c2ccc(cn2)-c2cccc(F)c2)C1 F2R 2149 thrombin receptor antagonist Other 5-FU CTRP.5;GDSC.179 BRD-K24844714 Fc1c[nH]c(=O)[nH]c1=O DPYD;TYMS 1806;7298 thymidylate synthase inhibitor DNA replication SN-38 CTRP.454;GDSC.1494 BRD-A36630025 CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2ccc(O)cc12 TOP1 7150 topoisomerase inhibitor DNA replication CAMPTOTHECIN GDSC.1003 BRD-K37890730 CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O TOP1 7150 topoisomerase inhibitor DNA replication TOPOTECAN CTRP.513;CCLE.14 BRD-K55696337 CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN(C)C)c4cc3Cn1c2=O TOP1;TOP1MT 7150;116447 topoisomerase inhibitor DNA replication IRINOTECAN CCLE.13;gCSI.9 BRD-K08547377 CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 TOP1;TOP1MT 7150;116447 topoisomerase inhibitor DNA replication DOXORUBICIN CTRP.221;GDSC.133;gCSI.5 BRD-K92093830 COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO TOP2A 7153 topoisomerase inhibitor DNA replication ETOPOSIDE CTRP.233;GDSC.134 BRD-K37798499 COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12 TOP2A;TOP2B 7153;7155 topoisomerase inhibitor DNA replication TENIPOSIDE CTRP.507 BRD-A35588707 COc1cc(cc(OC)c1O)[C@H]1[C@@H]2C(COC2=O)C(O[C@@H]2O[C@@H]3CO[C@H](OC3[C@H](O)[C@H]2O)c2cccs2)c2cc3OCOc3cc12 TOP2A;TOP2B 7153;7155 topoisomerase inhibitor DNA replication PIFITHRIN-ALPHA CTRP.418 BRD-K66874953 Cc1ccc(cc1)C(=O)Cn1c2CCCCc2sc1=N TP53 7157 TP53 inhibitor p53 pathway PRIMA-1 CTRP.425 BRD-K15318909 OCC1(CO)N2CCC(CC2)C1=O TP53 7157 TP53 reactivator p53 pathway RTRAIL GDSC.1261 TNFRSF10A;TNFRSF10B 8797;8795 TRAIL receptor agonist Apoptosis regulation HC-067047 CTRP.262 BRD-K03391209 Cc1c(cc(-c2ccccc2)n1CCCN1CCOCC1)C(=O)Nc1cccc(c1)C(F)(F)F TRPV4 59341 transient receptor potential channel antagonist Other PACLITAXEL CTRP.410;GDSC.11;CCLE.18;gCSI.13 BRD-A28746609 CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1 BCL2;MAP2;MAP4;MAPT;NR1I2;TLR4;TUBB;TUBB1 596;4133;4134;4137;8856;7099;203068;81027 tubulin polymerization inhibitor Mitosis DOCETAXEL CTRP.219;GDSC.1007;gCSI.4 BRD-A05821830 CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)C2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C([C@@H](O)C1=O)C2(C)C BCL2;MAP2;MAP4;MAPT;NR1I2;TUBB;TUBB1 596;4133;4134;4137;8856;203068;81027 tubulin polymerization inhibitor Mitosis VINORELBINE GDSC.140 BRD-K04269837;BRD-K69280563 CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O TUBA1A;TUBA1B;TUBA1C;TUBA3C;TUBA3D;TUBA3E;TUBA4A;TUBB;TUBB1;TUBB2A;TUBB2B;TUBB3;TUBB4A;TUBB4B;TUBB6;TUBB8 7846;10376;84790;7278;113457;112714;7277;203068;81027;7280;347733;10381;10382;10383;84617;347688 tubulin polymerization inhibitor Mitosis VINCRISTINE CTRP.530 BRD-K82109576 CC[C@]1(O)C[C@@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C=O)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC TUBA4A;TUBB 7277;203068 tubulin polymerization inhibitor Mitosis PARBENDAZOLE CTRP.414 BRD-K02407574 CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1 TUBB 203068 tubulin polymerization inhibitor Mitosis THALIDOMIDE CTRP.508 BRD-A93255169 O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12 CRBN;FGFR2;NFKB1;ORM1;ORM2;PTGS2;TNF 51185;2263;4790;5004;5005;5743;7124 tumor necrosis factor production inhibitor Protein stability and degradation TIVANTINIB CTRP.511 BRD-K33379087 O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23 MET 4233 tyrosine kinase inhibitor RTK signaling; Mitosis PYR-41 CTRP.408 BRD-K60750172 CCOC(=O)c1ccc(cc1)N1NC(=O)C(=Cc2ccc(o2)[N+]([O-])=O)C1=O ubiquitin activating enzyme inhibitor Protein stability and degradation IU1 CTRP.270 BRD-K45841694 Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1 USP14 9097 ubiquitin C-terminal hydrolase inhibitor Protein stability and degradation NSC632839 CTRP.356 BRD-K37392901 Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1 SENP2;USP1;USP2;USP7 59343;7398;9099;7874 ubiquitin specific protease inhibitor Protein stability and degradation MGCD-265 CTRP.314 BRD-K56277358 Cn1cnc(c1)-c1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)c2s1 AXL;MET 558;4233 VEGFR inhibitor RTK signaling TIVOZANIB CTRP.512;GDSC.312 BRD-K53414658 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC FLT1;FLT4;KDR;KIT;PDGFRA;PDGFRB 2321;2324;3791;3815;5156;5159 VEGFR inhibitor RTK signaling FORETINIB CTRP.241;GDSC.308 BRD-K03449891 COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1 FLT1;FLT4;KDR;MET 2321;2324;3791;4233 VEGFR inhibitor RTK signaling TKI258 CCLE.23 CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3 FLT1;KDR;FLT3;FLT4;FGFR1;FGFR3;KIT 2321;3791;2322;2324;2260;2261;3815 VEGFR inhibitor RTK signaling MK-1775 CTRP.318 BRD-K54256913 CN1CCN(CC1)c1ccc(Nc2ncc3c(n2)n(-c2cccc(n2)C(C)(C)O)n(CC=C)c3=O)cc1 WEE1 7465 WEE1 kinase inhibitor Cell cycle WEE1 INHIBITOR GDSC.1046 WEE1;CHEK1 7465;1111 WEE1 kinase inhibitor Cell cycle JW-74 CTRP.290 BRD-K75664313 COc1ccc(cc1)-n1c(SCc2nc(no2)-c2ccc(C)cc2)nnc1-c1ccncc1 TNKS;TNKS2 8658;80351 WNT signaling inhibitor; tankyrase inhibitor WNT signaling BIRINAPANT CTRP.154 BRD-K18589165 CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1cc2c(C[C@@H]3C[C@H](O)CN3C(=O)[C@H](CC)NC(=O)[C@H](C)NC)cc(F)cc2[nH]1 BIRC2;XIAP 329;331 XIAP inhibitor Apoptosis regulation BRD-K66453893 CTRP.114 BRD-K66453893 C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)S(=O)(=O)c2ccc(Cl)cc2)Oc2ccc(NC(=O)CCC(F)(F)F)cc2CC1=O Other BRD-K27224038 CTRP.82 BRD-K27224038 C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)C2CCOCC2)Oc2ncc(cc2C1=O)C#CC1(O)CCCC1 Other BRD-K14844214 CTRP.72 BRD-K14844214 CC(C)CC#Cc1ccc2c(O[C@@H](CN(C)C(=O)c3cnccn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1 Other BRD-K41597374 CTRP.97 BRD-K41597374 C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2cc(F)ccc2F)Oc2cc(ccc2S1(=O)=O)C#CC1CCCC1 Other BRD-K13999467 CTRP.71 BRD-K13999467 C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Cc2ccncc2)Oc2cc(ccc2S1(=O)=O)C#Cc1ccccc1F Other BRD-K96970199 CTRP.131 BRD-K96970199 C\C=C\c1ccc2c(O[C@@H](CN(C)C(=O)c3ccccc3)[C@@H](C)CN([C@@H](C)CO)S2(=O)=O)c1 Other BRD-K49290616 CTRP.103 BRD-K49290616 OC[C@@H]1O[C@@H](CC(=O)NCc2ccncn2)CC[C@H]1NC(=O)c1ccc(F)cc1 Other BRD-K02492147 CTRP.62 BRD-K02492147 CN1CCN(CC1)C(=O)C[C@@H]1O[C@H](CO)[C@@H](NS(=O)(=O)c2cccc(F)c2)C=C1 Other BRD-K09587429 CTRP.68 BRD-K09587429 C[C@@H](NC(=O)C[C@@H]1CC[C@@H](NC(=O)CN2CCOCC2)[C@H](CO)O1)c1ccccc1 Other BRD-K96431673 CTRP.130 BRD-K96431673 CN1CCN(CC1)C(=O)C[C@H]1CC[C@H](NC(=O)c2ccc3OCOc3c2)[C@@H](CO)O1 Other BRD-K86535717 CTRP.125 BRD-K86535717 CO[C@@H]1CC[C@H]2CCN(C)C(=O)[C@@H](C)[C@H](CN(C)C(=O)c3cccc(C#N)c3OC[C@H]1O2)OC Other BRD-K48334597 CTRP.101 BRD-K48334597 C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)NC2CCCCC2)Oc2ccc(NC(=O)Cc3cn(C)c4ccccc34)cc2C1=O Other BRD-K04800985 CTRP.65 BRD-K04800985 C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)CC2CCCCC2)Oc2ccc(NC(=O)Nc3c(C)noc3C)cc2C1=O Other BRD-K78574327 CTRP.120 BRD-K78574327 C[C@H](CO)N1C[C@H](C)[C@H](CN(C)CC2CC2)Oc2ccc(NS(=O)(=O)c3cn(C)cn3)cc2C1=O Other BRD-K19103580 CTRP.76 BRD-K19103580 C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc(Cl)c(Cl)c2)Oc2ccc(cc2C1=O)N(C)C Other BRD-K30019337 CTRP.87 BRD-K30019337 CC(C)NC(=O)N(C)C[C@H]1Oc2ccc(cc2C(=O)N(C[C@H]1C)[C@H](C)CO)N(C)C Other BRD-K84807411 CTRP.123 BRD-K84807411 C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C)Oc2c(NC(=O)c3cc(C)nn3C)cccc2C1=O Other BRD-K44224150 CTRP.99 BRD-K44224150 CNC[C@@H]1Oc2ccc(NC(=O)C3CCCCC3)cc2C(=O)N(C[C@@H]1C)[C@@H](C)CO Other BRD-K75293299 CTRP.119 BRD-K75293299 C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2cccc3ccccc23)Oc2c(NC(=O)c3ccncc3)cccc2C1=O Other BRD-K02251932 CTRP.61 BRD-K02251932 C[C@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2c(NS(=O)(=O)c3ccc(F)cc3)cccc2C1=O Other BRD-K41334119 CTRP.96 BRD-K41334119 CNC[C@@H]1Oc2ccc(NS(C)(=O)=O)cc2CC(=O)N(C[C@@H]1C)[C@H](C)CO Other BRD-K34485477 CTRP.93 BRD-K34485477 CNC[C@@H]1Oc2ccc(NC(=O)CCN3CCOCC3)cc2CC(=O)N(C[C@@H]1C)[C@H](C)CO Other BRD-K16147474 CTRP.74 BRD-K16147474 CC(C)NC(=O)Nc1ccc2O[C@@H](CN(C)S(C)(=O)=O)[C@@H](C)CN([C@H](C)CO)C(=O)Cc2c1 Other BRD-K29086754 CTRP.85 BRD-K29086754 C[C@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(O)=O)Oc2ccc(NC(=O)Nc3ccc(F)cc3)cc2CC1=O Other BRD-K33199242 CTRP.89 BRD-K33199242 CNC[C@@H]1Oc2ccc(cc2CC(=O)N(C[C@@H]1C)[C@@H](C)CO)N(C)C Other BRD-K52037352 CTRP.107 BRD-K52037352 C[C@@H](CO)N1C[C@H](C)[C@H](CN(C)C(=O)Nc2cccc3ccccc23)Oc2ccc(NC(=O)NC3CCCCC3)cc2CC1=O Other BRD-K37390332 CTRP.95 BRD-K37390332 C[C@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Nc2cccc3ccccc23)Oc2ccc(NC(=O)c3ccncc3)cc2CC1=O Other BRD-K50799972 CTRP.104 BRD-K50799972 COc1ccccc1-c1cccc(c1)-c1nc(cc2CN([C@@H](CCO)c12)[S@@](=O)C(C)(C)C)C(=O)NCc1ccncc1 Other BRD-K17060750 CTRP.75 BRD-K17060750 CN(C)CC(=O)N[C@@H]1CC[C@@H](CCNC(=O)Nc2ccc(F)cc2)O[C@H]1CO Other BRD-K45681478 CTRP.100 BRD-K45681478 ClC1=C(NCC=C)C(=O)c2ccccc2C1=O Other BRD-K63431240;BRD-K33514849 CTRP.112;CTRP.90 BRD-K63431240;BRD-K33514849 C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Nc2ccc3OCOc3c2)Oc2cc(ccc2S1(=O)=O)C#Cc1ccncc1 Other BRD-K27986637 CTRP.83 BRD-K27986637 C[C@H](CO)N1C[C@H](C)[C@H](CN(C)Cc2ccc3OCCOc3c2)OCc2cn(CCCC1=O)nn2 Other CIL55 CTRP.177 BRD-K46556387 CN(C)CCNC(=O)c1cc2CSc3cc(Cl)ccc3-c2s1 Other BRD4132 CTRP.138 BRD-K86574132 CC(C)N1C(=O)S\C(=C\c2ccc(Sc3nc4ccccc4[nH]3)o2)C1=O Other BRD6340 CTRP.139 BRD-K35716340 C(Cn1c2ccccc2c2ccccc12)c1nc2ccccc2[nH]1 Other BRD9647 CTRP.142 BRD-K05649647 COc1ccc(cc1)N(C(=O)c1ccccc1)S(=O)(=O)c1cc(OC)ccc1OC Other COMPOUND 1B CTRP.198 BRD-A42556028 CCN(CC)c1ccc(cc1[N+]([O-])=O)C1=NNC(=O)CC1C Other CIL56 CTRP.179 BRD-K11740178 ON=C1c2cc(ccc2-c2ccc(cc12)S(=O)(=O)N1CCCCC1)S(=O)(=O)N1CCCCC1 Other BRD-K92856060 CTRP.128 BRD-K92856060 COc1ccc(cc1[N+]([O-])=O)S(=O)(=O)N(C(C)=O)c1ccc(OC(C)=O)c2ccccc12 Other CIL41 CTRP.176 BRD-K05392795 N=C(NOC(=O)C12CC3CC(CC(C3)C1)C2)c1ccccc1 Other CIL70 CTRP.180 BRD-K20215950 Clc1ccc(CC(=N)NOC(=O)c2cccc3ccccc23)cc1 Other BRD-K90370028 CTRP.127 BRD-K90370028 CC(=O)N[C@@H]1C\C=C\CCC(=O)N[C@@H](COC1=O)c1ccccc1 Other BRD1812 CTRP.136 BRD-K73261812 Oc1ccc(C[C@@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc2ccccc2)cc1 Other BRD-K71781559 CTRP.117 BRD-K71781559 OC(=O)c1ccc(NCc2nc3cc4ccccc4cc3[nH]2)cc1 Other BRD-K01737880 CTRP.60 BRD-K01737880 COc1ccc(NC(=O)Nc2ccc3O[C@@H](CN(C)Cc4ccc5OCOc5c4)[C@@H](C)CN([C@@H](C)CO)C(=O)c3c2)cc1 Other BRD-K09344309 CTRP.67 BRD-K09344309 C[C@H](CO)N1C[C@@H](C)[C@H](CN(C)Cc2ccc3OCOc3c2)Oc2c(NC(=O)c3ccncc3)cccc2C1=O Other ELCPK CTRP.223 BRD-K44847641 O=S(=O)(N1CCCc2ccccc12)c1ccc(cc1)-c1cnc(o1)C1CC1 Other CIL55A CTRP.178 BRD-K69982010 CN(C)CCNC(=O)c1cc2CSc3ccc(Cl)cc3-c2s1 Other BRD-K48477130 CTRP.102 BRD-K48477130 Cc1n[nH]c2NC3=C([C@@H](c12)c1ccccc1)C(=O)CC(C)(C)C3 Other BRD-K34099515 CTRP.91 BRD-K34099515 CC(C)N1C[C@@H](C)[C@H](CN(C)Cc2ccc(Oc3ccccc3)cc2)Oc2c(NC(=O)c3ccncc3)cccc2C1=O Other BRD-K99006945 CTRP.133 BRD-K99006945 CCN(CC)c1ccc(cc1)C1=NNC(=O)C[C@H]1C Other BRD-A86708339 CTRP.58 BRD-A86708339 Cc1ccc(cc1)C(NC(=O)c1ccccc1)c1ccc2cccnc2c1O Other